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ABSTRACT 
  
Cardiovascular diseases are considered the leading cause of death nowadays. 
Hypertension, obesity and type-2 diabetes are deemed major risk factors for the 
development of cardiovascular diseases.  In essential hypertension, one of the most 
important structural changes is the inward remodeling of the resistance arteries. I found 
that the mechanical properties of inwardly remodeled cremasteric-arterioles from rats are 
affected. Furthermore, it is the F-actin components of the cytoskeleton the ones that are 
strongly modified. In old spontaneously hypertensive rats, my results showed that, 
resistance arteries undergo hypertrophic inward remodeling; and, adrenergic-
vasoconstriction and vasodilation pathways are impaired. In diet-induced-obesity, mice-
mesenteric arterioles were observed to undergo remodeling of the extracellular matrix 
components. Obesity and type-2 diabetes have been associated with insulin resistance, 
endothelial dysfunction and arterial stiffening. Jejunal-submucosal arterioles from 
diabetic obese patients had a reduced vasorelaxation to insulin in comparison to obese 
non-diabetics, while acetylcholine-vasodilation was similar in both groups. Reduced 
amounts of the subunit-alpha of the insulin receptor and MMP-9 were found in diabetics 
as well. This suggests that, in type-2 diabetes, the presence of a blunted insulin-
vasodilation response is a form of endothelial dysfunction that is not correlated with the 
body-to-mass index, but whose mechanism may be related with the activity of MMPs.  
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CHAPTER 1 
INTRODUCTION 
 
 In the most recent report published by the National Vital Statistics Reports in 
December of 2013 (74), the top 10 leading causes of death in the United States for 2010, 
which account for 75% of the total number of deaths, and their corresponding percentage 
of deaths are: Diseases of the heart (24.2%), Malign neoplasms (Cancer) (23.3%), 
Chronic lower respiratory diseases (5.6%), Cerebrovascular diseases (5.2%), Accidents 
(4.9%), Alzheimer’s disease (3.4%), Diabetes mellitus (2.8%), Nephritis, nephritic 
syndrome and nephrosis (2.0%), Influenza and pneumonia (2.0%), and Intentional self-
harm (suicide) (1.6%). From all these, heart diseases, cerebrovascular diseases and 
diabetes can be classified as cardiovascular and/or cardiovascular-related diseases, and 
they accounted for 32.2% of all deaths in the United States, becoming the major life 
threatening health condition.  
 
Hypertension is a chronic medical condition characterized by presence of elevated 
arterial blood pressure. It is considered an asymptomatic condition, in other words, it 
does not have any specific associated symptoms, which makes it even more difficult to 
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detect and to treat.  Hypertension is deemed a major risk factor for various heart and 
cerebrovascular diseases. This is the reason why it is very important to study and 
understand hypertension, from its early stages of development until the advanced stages 
where the vasculature undergoes functional and structural changes. 
 
Another major health problem with a dramatically increased prevalence 
worldwide in the last decade is obesity. In the years 2011-2012, it was reported that 
34.9% of the adults (>20 years old) in the United States were obese. Obesity has been 
associated with hypertension, and it is known to increase the risk for the development of 
cardiovascular diseases, type 2 diabetes, some respiratory diseases, and even cancer 
among others. 
 
The information contained in this dissertation focuses on the study, 
characterization and understanding of the main functional and structural modifications in 
the resistance vasculature that are associated with hypertension, type 2 diabetes and 
obesity.  
 
Chapters 2 and 3 will center in studying and understanding one of the main 
structural changes that is associated with essential hypertension known as inward 
remodeling of the resistance blood vessels. In Chapter 4, I will present and discuss the 
main results obtained from experimentation using the most commonly used animal model 
for hypertension, the spontaneously hypertensive rat. These three chapters are intended to 
give a thorough description of essential hypertension and the vascular functional and 
! 3!
structural changes associated with it, based on the results obtained during my doctoral 
research and the available literature.   
 
Chapter 5 covers the results obtained from an animal (mouse) model that was 
used to study the effects of a diet high in fats and carbohydrates on the vasculature and in 
the overall health of mice. These studies represent a good model for obesity in young and 
adult individuals, and allowed us to study the vascular dysfunctions and vascular 
remodeling and stiffening associated with obesity. 
 
Finally, in Chapter 6, I present and discuss some novel data obtained in a study 
conducted on human jejunal and mesenteric arteries. In that study we looked at the 
effects of obesity on the vasculature of adult humans undergoing bariatric surgery. 
Furthermore, we focused on understanding the connection between obesity and type 2 
diabetes. Previously, insulin resistance and endothelium dysfunction had been associated 
with obesity; however, whether there is a connection between these two, or not, had not 
been established.     
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CHAPTER 2 
MECHANISMS OF THE INWARD REMODELING PROCESS IN 
RESISTANCE VESSELS: IS THE ACTIN CYTOSKELETON 
INVOLVED?† 
 
2.1 Introduction 
 
Cardiovascular diseases are the most important life-threatening health conditions 
today, with hypertension and cerebrovascular disease being two of the most predominant 
ones, and projected to rapidly increase in the next few years (121). The majority of cases 
of hypertension are considered essential, as no apparent cause can be established for the 
elevated arterial pressure. Given the importance and the impact that hypertension has in 
human lives, a detailed study and better understanding of its pathophysiology is 
warranted, especially on the role that the structure and function of resistance vessels play 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!†!The research included in this chapter was originally published in Microcirculation. 
Castorena-Gonzalez, J. A. et al. Mechanisms of the inward remodeling process in resistance 
vessels: is the actin cytoskeleton involved?, Microcirculation, 2014 Apr; 21(3):219-29.              
doi: 10.1111/micc.12105. !!!
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in it, because recent studies indicate that remodeling of resistance arteries is one of the 
earliest detectable parameters that predict subsequent life threatening cardiovascular 
events (123, 156). In this article, we present a review of some of the main results from 
several studies that focused on the characterization of the most prominent structural 
changes that occur in the resistance vasculature in hypertension, i.e., the inward eutrophic 
remodeling of arterioles (11, 12, 120, 179, 194). We will present evidence that the inward 
eutrophic remodeling of arterioles is closely associated with augmented active tone 
induced via prolonged agonist-induced vasoconstriction, which stimulates structural 
modifications in the arteriolar wall, leading to changes in the elastic and mechanical 
properties of the vascular wall. Evidence indicates that during the initial stages of the 
remodeling process these changes occur mainly at the level of the actin cytoskeleton and 
are associated with the repositioning of vascular smooth muscle cells, actin 
polymerization pathways, and the accumulation of fibrillar (F)-actin. As results indicate 
that blockade of Rho and Rac-1 associated pathways prevent prolonged vasoconstriction 
from inducing inward eutrophic remodeling, we end with a hypothetical model of how 
these small GTPases may contribute to the remodeling process.  
 
2.2 Structure and elastic properties of resistance arteries 
 
The structure and composition of arterioles, and blood vessels in general, has been 
widely studied and described (114, 152, 153). However, much remains to be understood 
about the mechanics and interactions of the different components in the vessel wall. 
Resistance arteries play a preponderant role in the regulation of blood flow and 
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modulation of blood pressure in the cardiovascular system. For this reason, any structural 
change that occurs in the resistance vasculature, e.g., the narrowing of blood vessels, the 
thickening of vessel walls, increased/decreased stiffness, etc., can impact the mechanics 
of the arteriolar wall, the control of the cardiovascular system and the development of 
cardiovascular diseases (38). To characterize the mechanical properties of the blood 
vessel wall, the most common parameters studied are the stress, strain, and elastic 
modulus of vessels placed under passive condition.   
 
2.2.1 Circumferential stress 
The stress profile characterizes the internal forces exerted in between the 
individual components of a continuous material, for example, the forces in between 
adjacent smooth muscle cells in the vessel wall, due to an external force (e.g., 
intraluminal pressure). The stress represents an average force per unit-area. In the study 
of blood vessels associated with hypertension, the circumferential stress is more often 
examined as it contains information on the dimensions of the vascular luminal diameter 
and wall thickness at a given pressure, which are dimensions commonly affected by 
changes in blood pressure. In the microcirculation, circumferential stress is commonly 
expressed in dynes/cm2, and can be written as , where  
is the circumferential stress at the ith level of intraluminal pressure with its respective 
vascular diameter and wall thickness,  is the intraluminal pressure, and  and  are 
the internal diameter and the wall thickness at a given pressure, respectively. When 
studying resistance arteries, it is commonly assumed that the arteriolar wall volume 
remains constant under changes in pressure, at a fixed vessel length, this would result in a 
€ 
σθ ,i = (Pi ⋅ ri) /τ i = (Pi ⋅ Di) /2τ i
€ 
Pi
€ 
Di
€ 
τ i
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CSA (cross-sectional area) that remains constant. (18-20) In this case, the wall thickness 
could be calculated and expressed in terms of the CSA and the internal diameter as 
follows . 
 
2.2.2 Strain 
Strain is a normalized measure of the displacement between the components of a 
continuous material. In the case of blood vessels, the strain (circumferential strain) 
represents a measure of the change in internal diameter due to a change in intraluminal 
pressure normalized by a reference diameter, which normally is the diameter measurable 
at the lowest possible pressure (because vessels pressurized at 0 mmHg would collapse, 
pressures between 5-10 mmHg are commonly used as reference).  Being a normalized 
measure, the strain has no-units, and it can be written as , where  is 
the diameter at a given pressure and  is the reference diameter.  
 
2.2.3 Modulus of elasticity 
The modulus of elasticity, also known as tangential elastic modulus, is a 
parameter that measures the stiffness of an elastic continuous material. Mathematically it 
represents the point-by-point slope in a strain vs. stress curve. At every single point in 
this curve, the elastic modulus can be calculated as . 
 
Traditionally the extracellular matrix components of the vascular wall are 
considered the major contributors to the elastic properties of arterioles under passive 
conditions (85, 86, 193). Due to their relative amount and elastic properties, collagen and 
€ 
τ = (CSA /π ) + (Di2 /4) − (Di /2)
€ 
ε i = (Di −D0) /D0
€ 
Di
€ 
D0
€ 
ET ,i =σθ ,i /ε i
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elastin are the extracellular matrix components with major influence in vascular wall 
mechanics (193). However, to the best of our knowledge there are no systematic studies 
that have experimentally established the proportion by which different cellular and 
extracellular components of arterioles contribute to the elastic properties of the vascular 
wall. This is particularly important to establish in arterioles where smooth muscle is the 
major component of the vascular wall.  
 
Anatomically, the arteriolar wall is traditionally segmented from the lumen out 
into three different parts: The initma is composed of endothelial cells and a basement 
membrane. Endothelial cells are major contributors to the control of vascular tone. 
Evidence indicates that endothelial cells modify their intracellular (i.e., cytoskeletal) 
structure based on the shear stress they are exposed to as blood flows in the vascular 
lumen. It has also been shown that a number of mechanical and physiological 
mechanisms, and intracellular/cell-cell interactions are shear-stress mediated (e.g., 
production of nitric oxide and other vasodilator compounds, expression of nitric oxide 
synthase, presence and activity of adhesions between adjacent endothelial cells, cell 
membrane stability, cytoskeletal remodeling, etc.) (110, 112, 170, 182, 183, 190). The 
direct contribution of endothelial cells themselves to the elastic properties of the vascular 
under passive conditions, however, is likely to be minimal as indicated by experiments in 
which the vascular intima of arterioles has been denuded (50).  
 
The media, which in arterioles consists mostly of one or two layers of smooth 
muscle cells, is in charge of controlling the functional vascular diameter via mechanisms 
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of cellular contraction and relaxation. Recent results from our laboratory also suggest that 
in the early stages of the inward eutrophic remodeling process they provide a significant 
contribution to the passive diameter of arterioles (179). An additional component of the 
media in arterioles is the internal elastic lamina. The elastic laminas are constituted 
primarily of elastin fibers, which provide blood vessels with recoiling properties that 
allow them to expand and recover to their original diameter when external forces are 
applied and withdrawn. In inwardly remodeled arteries it has been shown that the fenestra 
(holes) present in the internal elastic lamina are reduced in size (27, 28), suggesting that 
remodeling of elastin may contribute to the reduction in passive diameter observed in 
inwardly remodeled vessels. In arterioles, the media is the thickest layer in the vascular 
wall. It contributes in a very important way to wall mechanics under active 
vasoconstriction. The contractile level of smooth muscle cells, the interactions in between 
multiple cells, the intracellular structure of the cell (e.g., actin cytoskeleton), and their 
interactions with the extracellular matrix including elastin molecules in the elastic 
laminas, will determine one of the major components of the elastic properties of the 
actively contracted arteriolar wall. The contribution of the media to the circumferential 
elastic properties of the arteriolar wall under passive conditions, however, appears to be 
minimal in “normal” arterioles obtained from normotensive rats, as actin cytoskeletal 
disruption or elastin degradation have no impact on maximal arteriolar passive diameter 
(40, 179). 
  
The adventitia, the outermost segment of blood vessels, is mainly composed of 
collagen and fibroblasts, which are embedded within the collagen. This layer is 
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considered to give support and structure to the arteriolar wall. It is considered to be a 
major contributor to vascular stiffness and elasticity, as collagen disruption severely 
affects vascular mechanics and is commonly used to dissociate the cellular elements of 
the wall.  
 
2.3 The inward remodeling of resistance arteries 
 
In essential hypertension, inward remodeling is the most commonly observed 
change in arteriolar structure. It is characterized by a reduced luminal diameter under 
passive conditions, and further categorized as eutrophic when the cross-sectional area of 
the vascular wall remains without significant changes (Fig. 2.1-A,B). It has been 
postulated that inward eutrophic remodeling occurs when resistance vessels exposed to 
high blood pressure are able to normalize circumferential stress via the repositioning of 
vascular smooth muscle cells around a smaller luminal diameter, a process that preserves 
wall cross-sectional area (70, 71, 117). If this process is insufficient, wall hypertrophy 
occurs to normalize the circumferential stress of the vascular wall.  
 
A reduced luminal diameter with a cross-sectional area that remains constant 
would cause the wall to lumen ratio to be increased, in other words, it would cause 
materials in the arteriolar wall to rearrange, leading to thickening of the arteriolar wall. 
An increased media to lumen ratio is an arteriolar feature commonly observed in essential 
hypertension, and based on the available evidence, is mainly due to rearrangement of the 
existent normal-sized cells around a smaller luminal diameter (11, 69). That is, there is no 
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cell hypertrophy or hyperplasia. It is important to consider that any structural 
modifications in the arteriolar wall would induce changes in the viscoelastic properties 
and mechanics of the vessel. However, the overall change in vascular mechanics would 
depend on the viscoelastic characteristics of the materials being modified and the relative 
amount of these materials in the arteriolar wall.      
 
As an example, let us consider the curves shown in Figure 2.1, where the elastic 
characteristics of a control (non-remodeled) and an inwardly eutrophic remodeled 
arteriole are compared. From the equations for stress, strain and elastic modulus 
presented in the previous section, we know that the stress is directly proportional to the 
inner diameter and inversely proportional to wall thickness. In Figure 2.1-B, the inner 
passive diameter in the remodeled vessels is smaller than the control at all intravascular 
pressures. The resulting strain-stress relationship of these two vessels is represented in 
Figure 2.1-C. Notice that the point-by-point circumferential stress at a given level of 
strain is greater in the remodeled arteriole. However the greatest level of stress achieved 
at the highest intraluminal pressure is slightly reduced after remodeling because the 
remodeled vessel is less pliable and distended less at the highest pressure. In the 
remodeled vessel, the strain has been substantially reduced (i.e., is less distensible) due to 
the stiffening (increased modulus of elasticity) of the arteriolar wall (Figure 2.1-C, D). 
 
The mechanisms that control inward eutrophic remodeling have not been 
completely elucidated, in particular those associated with the initial stages of the process. 
Overall, substantial evidence indicates prolonged vasoconstriction is a primary condition 
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that induces inward remodeling (12, 71, 115, 120). Whether all stimuli capable of 
inducing prolonged vasoconstriction can also cause inward eutrophic remodeling has not 
been clearly established. However, cumulative in vivo and ex vivo studies suggest that 
prolonged agonist-dependent stimulation for vasoconstriction induces inward remodeling 
in resistance vessels.  
 
 
Figure 2.1. Structural and mechanical characteristics of an inwardly remodeled resistance artery. 
(A) Diagrammatic representation describing the main changes in inner and outer diameters and CSA 
observed in the arteriolar wall of arterioles with inward eutrophic remodeling. (B) Diagrammatic 
representation of the intraluminal pressure to passive diameter relationships of a control and an inwardly 
remodeled arteriole. (C) Diagrammatic representation of the strain–stress relationships of the control and 
inwardly remodeled arterioles presented in Panel B. (D) Diagrammatic representation of the moduli of 
elasticity obtained from the control and inwardly remodeled arterioles presented in Panel B.  
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Accordingly, prolonged exposure of isolated arterioles to vasoconstrictors such as 
endothelin-1, norepinephrine, and angiotensin II has been shown to cause inward 
remodeling (12, 115). In vivo, prolonged infusion or expression of vasoconstrictor 
agonists induces inward remodeling as well (37, 71, 209). A number of results suggest 
that the level of vasoconstriction achieved by the agonists corresponds to the level of 
reduction in passive diameter observed in the remodeled vessel (115). However, this does 
not appear to be the case for all agonists (115). Additional studies suggest that, in vivo, 
the overall influence that vasoconstrictor or vasodilator agonists have on a vascular 
segment is able to control the remodeling process (122, 168). This is particularly evident 
in experiments showing that a diminished vasodilator influence caused by a reduction in 
blood flow and shear stress-dependent production of nitric oxide and activation of 
transglutaminase activity causes inward remodeling in resistance arteries (11, 13, 51). 
 
The mechanisms associated with the inward remodeling process achieved either 
by prolonged exposure to vasoconstrictor agonists or a reduction in blood flow have been 
associated with processes that involve multiple factors, such as reactive oxygen species 
(ROS), nitric oxide, Rho, Rac-1, matrix metalloproteinases (MMP), and tissue type 
transglutaminase (TG2) among others (11, 51, 120, 179). All of these factors have the 
potential to affect cytoskeletal and extracellular matrix structures of the vascular wall. 
However, how these factors participate in the remodeling process both temporally and 
mechanistically remains to be fully elucidated. Recently we reported that during the early 
stages of the inward eutrophic remodeling process, nearly 75% of the reduction in passive 
diameter observed in isolated arterioles constricted for four hours was reversed following 
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actin cytoskeletal disruption. Below we present a brief review of some of the known and 
proposed roles some of the above mentioned factors play on the actin cytoskeleton and 
potentially on the inward remodeling process.  
 
2.4 Vasoconstriction and actin polymerization  
 
Over the last several years, it has become evident that calcium sensitization and 
actin polymerization processes participate in the contraction of smooth muscle. These 
pathways appear to intermingle and collaborate with the classical pathway of constriction 
induced by increments in intracellular calcium concentration and the subsequent increase 
in myosin light chain phosphorylation and actomyosin cross bridge cycling (Fig. 2.2). 
Studies performed in different types of smooth muscle including airway, vascular, and 
intestinal muscle indicate that exposure to contractile agonists induces the polymerization 
of actin and that this actin polymerization is required for the development of force (2, 128, 
138, 141, 151, 161, 188). Importantly, results also indicate that inhibition of actin 
polymerization by agents such as cytochalasin-D or latrunculin-A do not affect the 
signaling pathways that regulate myosin light chain phosphorylation during smooth 
muscle contraction (43, 161).  
 
Evidence suggests that the actin polymerization pathways taking place upon 
stimulation for constriction serve to strengthen a scaffold of actin fibers (primarily 
cortical actin) that allows for contractile fibers to exert force appropriately, and shorten 
the cell (204). Hypothetically a reversed loosening of these structures occurs during cell 
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relaxation in response to contractile agonists withdrawal or in the presence of relaxing 
compounds. In support of this hypothesis a recent study reported that the cortical stiffness 
of isolated vascular smooth muscle cells increases in response to stimulation with the 
vasoconstrictor agonist angiotensin II, and is reduced upon exposure to a vasodilator (78).  
 
 
Figure 2.2. Vascular smooth muscle intracellular mechanisms for vasoconstriction. VSMC located 
in the medial layer of resistance arteries reduce their length to cause vasoconstriction. This process involves 
mechanisms associated with the phosphorylation of MLC20, and the formation and disruption of actin 
cytoskeletal structures. The activation of ROCK is an event that potentially links MLC-20 phosphorylation 
and actin polymerization mechanisms. ROCK inactivates MLCP to maintain MLC-20 phosphorylation and 
constriction. It also deactivates cofilin and its severing action on actin filaments via the activation of LIMK. 
Consequently, integrin-linked actin fibers are able to polymerize and strengthen the cytoskeleton through 
processes that involve the phosphorylation of paxillin and a number of other focal adhesion proteins with 
and without kinase activity. GPCRs, G-protein coupled receptors; IEL, internal elastic lamina; PLC, 
phospholipase C; IP3, inositol triphosphate; DAG, diacyl glycerol; RhoGEF, Rho guanine exchange factor; 
MLCK, myosin light- chain kinase; FAK, focal adhesion kinase. Figure adapted from references (64, 117). 
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In vascular structures some results suggest that actin polymerization increases as 
vasoconstriction is prolonged (151). In accordance with those results, we recently 
reported that stimulation of isolated arterioles for four hours with the vasoconstrictor 
agonists norepinephrine and angiotensin II increased the ratio of filamentous (F) to 
globular monomeric (G) actin obtained by differential centrifugation of the tissue (179). 
Our results further suggest that some actin structures formed during the prolonged 
exposure to the vasoconstrictor agonists are not readily disrupted by withdrawal of the 
vasoconstrictor agonists, exposure to vasodilator compounds, or removal of calcium. 
Only the active severing disruption of actin filaments with mycalolide B was able to 
allow for vascular relaxation to passive diameters similar to those observed before the 
prolonged exposure to the vasoconstrictor agonists. We hypothesize that during 
prolonged periods of vasoconstriction “more permanent” actin cytoskeletal structures are 
formed through actin polymerization pathways. These “more permanent” cytoskeletal 
structures may be part of the existing cytoskeleton or may represent new cellular 
processes of the vascular smooth muscle cells that re-elongate and reposition themselves 
in the arteriolar wall during the remodeling process (see below). Our results suggest that 
in the initial stages of the inward remodeling process the establishment of these structures 
does not allow the vessel to dilate to its previous maximal passive diameter. 
  
The generation of filamentous F-actin occurs via the aggregation of globular G-
actin monomers into oligomers that are subsequently elongated to form a polarized 
filament. During the elongation phase, ATP bound monomers are added to both ends of 
the growing filament, though the rate of addition is not equal, as the designated plus end 
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adds monomers at a much greater rate than the minus end. Once incorporated into 
filaments, the actin monomers can undergo nucleotide hydrolysis, thereby increasing the 
rate at which they disassociate from the filament. This dissociation predominantly occurs 
at the minus end. As the filament grows, the local concentration of G-actin decreases and 
the filament achieves a steady state equilibrium in which the rate of actin monomer 
incorporation at the plus end equals the rate of monomers disassociating from the minus 
end. Throughout this process a host of proteins interact with G and F-actin to maintain 
and regulate not only filament assembly and elongation, but also filament stability and 
disassembly.  
 
The formation of actin dimers and trimers, termed nucleation, appears to be the 
rate-limiting step in F-actin polymerization. The dissociation constant (Kd) for actin 
dimers has been estimated to be as high as 4.6 M (175).  To overcome this kinetic barrier, 
cells utilize a number of actin regulators to promote nucleation. To date, three main 
classes of nucleators have been described in the literature: the Arp2/3 complex, formins 
and Spire. The activity of the nucleators is controlled by nucleation promoting factors 
(NPFs). It is well established that in response to vasoconstrictor stimuli actin 
polymerization is required for maximum force generation as well as for maintenance of 
constriction in vascular smooth muscle cells (for review see (64)). It is less clear which 
nucleator (or combination of nucleators) mediates actin polymerization during 
constriction of resistance arteries. However, the Arp 2/3 complex has been implicated in 
the process. The NPF, neuronal Wiskott-Aldrich Syndrome Protein (N-WASp), activates 
the Arp 2/3 complex and promotes nucleation and actin polymerization. In rat mesenteric 
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arteries exposed to phenylephrine, inhibition of N-WASp association with the Arp 2/3 
complex decreases the extent of constriction and dampens the increase in the ratio of F- 
to G-actin (an indicator of actin polymerization) (8). It has also been shown that the 
Arp2/3 complex is a component of adhesion complexes that are formed following 
activation of integrins (48). Integrins are transmembrane receptor proteins that link the 
extracellular matrix (ECM) to the cytoskeleton and, in addition to other functions, 
facilitate cell motility by regulating actin polymerization at adhesion sites (23).  They 
also play a role in vascular remodeling, as inhibition of αV integrins blocked inward 
eutrophic remodeling in rat resistance vessels (71). Interestingly, formins have also been 
identified in purified adhesion complexes that promote actin polymerization (29). 
However, it is not clear what effect, if any, they have on actin polymerization in vascular 
smooth muscle cells in response to contractile stimulation.  
 
In addition to assembly, actin filament disassembly is also highly regulated. 
Cofilin-1 is a member of the Actin-depolymerizing factor/cofilin family and, when active, 
is able to bind adenosine diphosphate subunits in F-actin and sever actin filaments (130). 
Paradoxically, cofilin’s depolymerizing effects are concentration dependent.  At 
relatively high concentrations, the severing activity of cofilin promotes actin nucleation 
by increasing the availability of free monomers to oligomerize. In addition, it is 
postulated that direct binding of cofilin with actin dimers promotes their stabilization, 
thereby decreasing the rate of dimer disassociation (6). Cofilin’s ability to bind to actin is 
inhibited by its phosphorylation at position Ser3 by Lim Kinase (205). Interestingly, the 
signaling pathways of numerous vasoconstrictor agonists lead to Lim Kinase activation, 
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as Rho associated kinase phosphorylates and activates Lim Kinase (Fig. 2) (142). It 
remains to be determined what role cofilin and Lim kinase play in vasoconstriction of 
resistance vessels, and the subsequent development of inward remodeling. Since actin 
polymerization is required for inducing inward remodeling in resistance vessels, we are 
intrigued by the possibility that Lim kinase could potentially regulate the process by 
inactivating cofilin, thereby shifting the actin dynamics towards increased polymerization.  
 
2.5 Matrix metalloproteinases, inward remodeling and the cytoskeleton 
 
Inward remodeling induced ex vivo by prolonged vasoconstriction of isolated 
arterioles or in vivo in animal models of hypertension has been associated with the 
production of ROS and MMP activity (34, 35, 120). MMP activity is for the most part 
associated with extracellular matrix degradation, but there are a number of ways by 
which MMPs may modulate cytoskeletal structures. The degradation of extracellular 
matrix structures creates protein fragments with exposed cryptic sites that activate 
integrins (118). Integrin activation in turn activates intracellular signals that induce 
cytoskeletal modifications. Interestingly, the activation of specific integrins is also 
required for the inward eutrophic remodeling of resistance arteries observed in the Ren2 
rat model of hypertension (71).  Additional pathways by which MMPs can induce 
cytoskeletal modifications include the transactivation the epidermal growth factor 
receptor as it occurs upon stimulation with vasoconstrictor agonists such as 
norepinephrine and angiotensin II (132, 198). The formation of vasoactive compounds 
such as the vasoconstrictor fragments of endothelin created by the cleavage of big 
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endothelin-1 (57), is another mechanism by which MMPs could induce cytoskeletal 
modifications and arteriolar inward remodeling. In isolated arterioles we previously 
showed that prolonged stimulation with norepinephrine and angiotensin II resulted in an 
increased expression of MMP-2, and an increased level of gelatinolytic activity that was 
dependent on the production of ROS (120). Furthermore, we showed that broad MMP 
inhibition did not affect the production of ROS but prevented the remodeling induced by 
prolonged vasoconstriction. In contrast, inhibition of ROS prevented both the activation 
of MMPs and the inward remodeling, suggesting that ROS-dependent activation of 
MMPs is involved in the development of the remodeling process (120).    
 
2.6 Inward remodeling, transglutaminase activity and the actin 
cytoskeleton 
 
The role of transglutaminase activity on the inward remodeling process of 
resistance arteries was first demonstrated in a seminal study by Bakker et al. (11). In that 
study the authors showed that the inward remodeling induced in vivo by low flow or ex 
vivo by prolonged exposure to endothelin-1 could be blocked with inhibitors of TG2 
activity (11).  They also showed that exogenous application of TG2 or its increased 
expression in response to retinoic acid exposure also induced inward remodeling in 
isolated resistance arteries (11). The transglutaminases are a family of enzymes that 
promote transamidation, covalently linking a lysine from one protein with the glutamine 
of another under high calcium conditions such as those found extracellularly (14). 
Consequently, the role of TG2 on vascular remodeling has been shown and presumed to 
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include extracellular matrix crosslinking (11, 194). The role of TG2 on remodeling of the 
vascular extracellular matrix has also been shown to include vascular calcification in 
conduit arteries (36, 90). However, in addition to the well-known extracellular matrix 
cross-linking functions of TG2, this enzyme is known to contribute to and catalyze other 
reactions that impact cytoskeletal structures (137). For example, TG2 has the capability 
to function as a G-protein, with the potential triggering of pathways that stimulate the 
activity of small GTPases such as Rho and its downstream effector ROCK leading to the 
remodeling of the actin cytoskeleton via mechanisms such as the polymerization of actin, 
the stabilization of existent actin fibers and the inhibition of actin depolymerization (137). 
The activation of TG2 at the cell membrane and its association with integrin receptors 
also has the potential to cluster cell adhesion sites and initiate integrin dependent outside 
in signaling pathways that lead to cytoskeletal remodeling (14, 118). The association that 
exists between TG2 and intracellular stress fibers suggests that TG2 may also help in the 
formation and stabilization of those fibers. Therefore the role of the transglutaminases on 
the inward remodeling process of resistance arteries needs to be further investigated to 
determine their potential participation on the initial stages of the process, which we have 
shown includes cytoskeletal modifications, and on the specific extracellular matrix 
changes TG2 causes on inwardly remodeled vessels.  
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2.7 Rho, Rac and the role of smooth muscle cell motility in arteriolar 
remodeling 
 
The majority of smooth muscle cells within the vessel wall are found in a 
differentiated state called the contractile phenotype. This differentiated state is 
characterized by low proliferative capabilities, specific cellular morphologies (i.e., 
elongated and spindle shaped) and by the expression of contractile molecular markers 
such as smoothelin, α-smooth muscle actin and smooth muscle-myosin heavy chain. 
During the remodeling of large conduit vessels (e.g., aorta, carotid artery) encountered in 
vascular injury, hypertension and atherosclerosis, the contractile smooth muscle cells 
undergo a process of dedifferentiation towards a synthetic phenotype. An important 
characteristic of the synthetic phenotype is that the smooth muscle cells acquire the 
capacity to proliferate and migrate in response to extracellular stimuli such as angiotensin 
II, norepinephrine, and extracellular matrix fragments. In large conduit arteries, vascular 
smooth muscle cell migratory behavior has been documented both in vitro and in vivo 
(22, 89, 101). However the role of smooth muscle cell migration in the microcirculation 
has not been investigated. We have previously reported that repositioning of smooth 
muscle cells from the medial layer of resistance arteries is one of the mechanisms 
associated with inward eutrophic remodeling (116). We found that after only four hours 
of exposure to vasoconstrictor agonists, the vessels manifested structural changes 
consistent with inward remodeling (115, 116, 120, 179). Using multiphoton microscopy, 
it was determined that the reduction in luminal diameter was associated with the 
rearrangement of a number of smooth muscle cells relative to each other.  These smooth 
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muscle cells relengthened and increased their overlapping along their longitudinal axis 
during the continual exposure to contractile agonists. As mentioned above, in this type of 
remodeling the cross-sectional area of the vessel wall does not change, while the passive 
luminal diameter is reduced. This suggests that the reduction in luminal diameter is 
accomplished by the rearrangement of the same amount of wall material, including 
smooth muscle cells, around a smaller vascular lumen. Our results suggest that a number 
of smooth muscle cells reposition around a smaller lumen resulting in luminal narrowing 
and impaired capacity for dilation. Although the cytoskeleton was not specifically 
investigated in that study, the repositioning of the smooth muscle cells likely requires a 
coordinated rearrangement of cytoskeletal structures in addition to the acto-myosin cross 
bridge cycling associated with smooth muscle cell contraction. Furthermore, the 
cytoskeletal reorganization is likely coordinated with changes in cell-matrix adhesions 
(78), as suggested by studies indicating that integrin associated mechanisms are required 
for the inward eutrophic remodeling process to occur (70, 71).   
 
Actin cytoskeleton reorganization and dynamics are critical for smooth muscle 
cell movement and are associated with changes in cell shape and polarity (68). The cell 
movement is coordinated by the key regulators of the cytoskeleton, Rho, Rac and Cdc42. 
These small GTPases control numerous aspects of actin-filament turnover and assembly 
(94, 154). Each GTPase can induce different changes in the cytoskeleton. For example, 
Rho activation results in the formation of stress fibers which contain acto-myosin 
filaments and are associated with focal adhesion complexes (155). Also, through its 
downstream target Rho kinase (ROCK), Rho is associated with calcium sensitization 
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(177). In comparison, Rac activation induces the formation of membrane ruffles and 
lamellipodia leading to reorganization of the cytoskeleton (135). Cdc42 has been shown 
to induce the formation of filopodia. Cdc42 activation, induced by exposure to contractile 
agonists, has also been shown to control actin polymerization and active tension 
development in tracheal smooth muscle cells (102, 136). In a recent study from our 
laboratory we investigated the role of the small GTPases in the inward remodeling 
process of resistance arteries (179). Using isolated vessels, we determined that ROCK or 
Rac-1 inhibition with the pharmacological agents Y27632 or NSC23766, respectively, 
prevented the inward eutrophic remodeling induced by prolonged exposure to contractile 
agonists. ROCK inhibition prevented the maintenance of agonist induced constriction and 
inward remodeling, while Rac-1 inhibition prevented the remodeling but allowed 
prolonged vasoconstriction to be maintained. We also found that ROCK inhibition 
interfered with the maintenance of basal tone. This is consistent with studies showing that 
in pressurized vessels Rho-ROCK pathways maintain calcium sensitivity in the absence 
of vasoconstrictor agonists (107, 171, 196), and with studies showing that ROCK affects 
actin polymerization (42). That the early remodeling process was dependent on actin 
cytoskeletal modification was corroborated by the observation that actin fiber disruption 
reversed the inward remodeling caused by prolonged vasoconstriction. However, the 
pathways involved in inward remodeling that are more likely to be affected by the 
pharmacological blockade of ROCK or Rac-1 remain to be experimentally determined.  
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Taken together our studies suggest that the early phases of constriction-induced 
inward remodeling involve the dynamic reorganization of smooth muscle cells around a 
smaller lumen. This rearrangement appears to be dependent on the actin cytoskeletal 
reorganization orchestrated by the small GTPases Rho and Rac. A possible mechanism of 
remodeling would involve two concomitant processes. First, once the smooth cells are 
exposed to contractile agonists they begin to constrict and continue to maintain the 
constriction over time. This process is dependent mainly on the Rho-ROCK pathway. In 
parallel with this process a number of smooth muscle cells relengthen, readjust their 
position within the media and increase their cellular overlap. This latter process might be 
locally and temporally coordinated by the interplay between Rho, Rac and Cdc42 
pathways. During this process of readjustment, the cells might extend lamellipodia and 
filopodia coordinated by Rac and possibly Cdc42, while simultaneously forming stress 
fibers through Rho activity. This model is consistent with our findings that ROCK 
inhibition prevents both the maintenance of constriction and remodeling, whereas Rac 
inhibition only prevents the remodeling without affecting acute or prolonged constriction. 
However, the validity of this model needs to be confirmed experimentally.       
 
2.8 Conclusions and future directions 
 
A substantial number of studies provide strong evidence that a number of 
cardiovascular diseases are associated with structural changes in resistance arteries, with 
inward eutrophic remodeling being the most prevalent in hypertension. Results from 
recent studies have associated the development of inward eutrophic remodeling with 
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processes that involve prolonged vasoconstriction, actin polymerization, transglutaminase 
activity and ROS-dependent activation of MMPs. However, a complete pathway that 
connects all these phenomena, and provides a full temporal and mechanistic description 
of the remodeling process is still warranted. Additional studies should therefore 
investigate the temporal associations and interactions that link prolonged vasoconstriction 
with actin polymerization pathways, the oxidative state of cells, activation of MMPs and 
transglutaminase activity. Elucidation of these associations and interactions should 
provide a clearer view of the mechanisms that control inward eutrophic remodeling and 
consequently present targets for therapeutic intervention and reduction of the life 
threatening events associated with resistance vessel remodeling.  
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CHAPTER 3 
THE OBLIGATORY ROLE OF THE ACTIN CYTOSKELETON ON 
INWARD REMODELING INDUCED BY DITHIOTHREITOL (DTT) 
ACTIVATION OF ENDOGENOUS TRANSGLUTAMINASE IN 
ISOLATED ARTERIOLES‡ 
 
3.1 Introduction 
 
Inward remodeling of arterioles is the most prevalent structural change of the 
resistance vasculature observed in patients with hypertension and diabetes (69, 157). Its 
presence is associated with an increased risk for life threatening cardiovascular events 
including stroke and myocardial infarction (123, 156). However, despite its clinical 
importance, the mechanism(s) responsible for its development have not been completely 
elucidated. !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
‡ The research included in this chapter was originally published in American Journal of 
Physiology – Heart and Circulatory Physiology 
Castorena-Gonzalez, J. A. et al. The obligatory role of the actin cytoskeleton on inward 
remodeling induced by dithiothreitol activation of endogenous transglutaminase in isolated 
arterioles. Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H485-95.                               
doi: 10.1152/ajpheart.00557.2013. Epub 2013 Dec 13. !
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Cumulative evidence indicates that prolonged exposure to vasoconstrictor 
agonists causes inward remodeling of arterioles. Ex vivo, prolonged vasoconstriction 
induced by exposure of isolated arterioles to endothelin-1, angiotensin II, norepinephrine, 
or serum causes inward remodeling (15, 16, 115). In vivo, vasoconstriction also appears 
to be the primary stimulus causing inward remodeling in hypertension, as vasodilation 
and not a mere reduction in blood pressure is needed to prevent or revert inward 
remodeling in hypertensive individuals (39, 122). The mechanism(s) responsible for 
inducing remodeling during prolonged vasoconstriction, however, remain elusive. 
 
A series of recent studies indicates that inward remodeling of arterioles requires 
transglutaminase activity. In 2005 Bakker et al. showed that the inward remodeling 
induced by prolonged exposure of isolated arterioles to endothelin-1 was prevented by 
incubation with the inhibitors of transglutaminase, cystamine, or 5-(biotinamido) 
pentylamide (11). In vivo, it has also been shown that inhibition of transglutaminase 
activity with cystamine prevents the inward remodeling observed in mesenteric arterioles 
of rats subjected to prolonged infusion with phenylephrine or a local reduction in blood 
flow (11, 53). In conduit arteries, Santhanam et al. (166) showed that the reduced 
distensibility observed in carotid arteries of mice treated with the nitric oxide synthase 
inhibitor L-NGnitroarginine methyl ester (L-NAME) was greater in wild type animals 
than in those not expressing tissue-type transglutaminase. They also observed that the 
increased pulse wave velocity observed in old rats was diminished after treatment with 
cystamine, suggesting that inhibition of transglutaminase activity reduces aortic stiffness 
(166).  
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As transglutaminase activity is known to participate in the crosslinking of extracellular 
matrix proteins, it has been proposed that inward remodeling and vascular stiffness occur 
as transglutaminase crosslinks extracellular matrix proteins of vessels with reduced 
diameters and thus prevents subsequent vessel diameter expansion (11, 166).   
 
Evidence is also accumulating that indicates the process of vasoconstriction 
involves the activation of small GTP binding proteins and the polymerization of actin 
within vascular smooth muscle cells (99). Recently we demonstrated that inhibition of 
actin polymerization or the signaling pathways associated with the activity of the small 
GTP binding proteins, Rho and Rac, prevents prolonged vasoconstriction from inducing 
inward remodeling in isolated arterioles (179). Moreover, we showed that nearly 75% of 
the structural reduction in passive diameter observed in the early stages of 
vasoconstriction-induced inward remodeling is reversible upon the enzymatic 
depolymerization of F-actin (179). Other studies have shown that dithiothreitol (DTT) 
induces inward remodeling in isolated arterioles via the activation of endogenous 
transglutaminases (194), and that DTT induces vasoconstriction in isolated arteries (59, 
60). Moreover, transglutaminase activity is known to activate RhoA (88). Therefore, we 
designed the present study to test the hypothesis that prolonged activation of endogenous 
transglutaminase with DTT reduces the passive diameter of arterioles through processes 
that depend on actin cytoskeletal structures and require actin polymerization and 
vasoconstriction.  
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3.2 Materials and methods !
3.2.1 Animals 
Male Sprague-Dawley rats (~200 g) were used in all experiments. All animal 
protocols and procedures implemented during these studies were approved by the Animal 
Care Quality Assurance office (ACQA) and the Animal Care and Use Committee 
(ACUC) at the University of Missouri-Columbia. Before experimentation rats were 
housed in pairs under a 12-hour per day illumination regimen and provided with ad 
libitum access to standard rat chow and water. 
 
3.2.2 Vessel isolation 
Rats were anesthetized by means of an intraperitoneal injection of pentobarbital 
sodium at a dose of 100 mg/Kg.  After confirmation that spinal reflexes were lost, both 
cremaster muscles were excised and placed in a cold (~4°C) physiological saline solution 
(PSS) containing: 145.0 NaCl, 4.7 KCl, 2.0 CaCl2, 1.0 MgSO4, 1.2 NaH2PO4, 0.02 
EDTA, 2.0 Pyruvic Acid, 5.0 Glucose and 3.0 MOPS (all concentrations are given in 
mM) with a final pH of 7.4. First order (1A) feed arterioles from each cremaster were 
isolated, cannulated and pressurized for experimentation as previously described (115). 
Briefly, arteriolar segments of ~1mm in length were cannulated onto glass micropipettes 
within an observation chamber (Living Systems Instrumentation, Burlington, Vermont) 
filled with PSS. The arterioles were pressurized without flow to 60 mmHg using a 
Pressure Servo System (Living Systems Instrumentation Burlington, Vermont) and PSS 
containing 0.15 mM bovine serum albumin. The observation chamber with the 
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cannulated vessel was transferred to an inverted microscope equipped with a video 
display and video caliper system (Living Systems Instrumentation Burlington, Vermont) 
to record measurements of wall thickness and luminal diameter. All experiments were 
performed at 34.5°C. 
 
3.2.3 Experimental protocols 
Assessment of endogenous transglutaminase activation by DTT in isolated 
arterioles 
To determine relative transglutaminase activity, isolated arteriolar segments were 
incubated with the transglutaminase substrate Alexa Fluor 488 cadaverine. Rat cremaster 
1A arterioles were isolated and then transferred to 1.5 mL tubes containing 10µM 
cadaverine in PSS and incubated over night at 4°C. The next day, vessels were warmed to 
37°C and incubated in one of the following treatments: PSS + 10 µM cadaverine 
(Control), PSS + 200 µM DTT + 10 µM cadaverine (DTT), and PSS + 200 µM DTT + 
1.0mM cystamine + 10 µM cadaverine (DTT + cystamine) for 4 hours at 37°C. All 
subsequent steps were performed at 4 °C. Vessels were washed twice in phosphate 
buffered saline (PBS), then fixed for 1 hour in 4% paraformaldehyde. Vessels were 
washed twice in PBS and then incubated for 1 hour in 2.0µM 4',6-diamidino-2-
phenylindole (DAPI) in PBS + 10% bovine serum albumin (BSA) to visualize nuclei. 
Vessels were washed 3 times in wash buffer followed by 2-time wash in PBS. Vessels 
were then imaged using a Leica SP5 confocal microscope with a 63x/1.2 numerical 
aperture water objective. Cadaverine was excited with an Argon laser at 488 nm. DAPI 
was excited with a multi-photon laser at 720 nm. Images were processed and quantified 
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using Imaris software. For quantification, a region of interest (ROI) was selected 
containing predominantly vascular smooth muscle cells. ROI ! 40µm x 40µm x 15µm. 
The mean fluorescent intensity per µm3 was determined for the ROI, n ≥ 5 for all 
treatments.  
 
Effects of acute activation of endogenous transglutaminase on arteriolar tone  
To determine the acute effect of endogenous transglutaminase activation on 
arteriolar function, isolated arterioles with spontaneous myogenic tone were exposed 
abluminally to increasing concentrations of DTT (10-6.5 to 10-3 M) in the absence or 
presence of the transglutaminase inhibitor, cystamine (1 mM). Cystamine has been 
previously used at concentrations of 0.1 and 1 mM to inhibit the activity of 
transglutaminase in vascular tissues (11, 91). In our experiments designed to inhibit 
transglutaminase activity, cystamine was added to the superfusate 20 minutes before and 
at all times during exposure to DTT. In an additional series of experiments, arterioles 
were incubated with 500 nM cytochalasin-D 20 minutes before and at all times during 
exposure to increasing concentrations of DTT in order to block actin polymerization 
(179). To construct vessel diameter response curves, each concentration of DTT was 
maintained for 5 minutes in the absence or presence of cystamine or cytochalasin-D.  
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Effects of prolonged activation of endogenous transglutaminase on arteriolar 
remodeling 
To confirm previous observations that prolonged activation of endogenous 
transglutaminase induces arteriolar inward remodeling (11, 194), isolated arterioles 
pressurized to 60 mmHg were exposed to 200 µM DTT for 4 hours in the absence or 
presence of 500 nM cytochalasin-D. We chose a concentration of 200 µM DTT because 
it induced a submaximal constriction of arterioles that is completely blocked by 1 mM 
cystamine (Fig. 3.1-C). Before and after the prolonged exposure to DTT arterioles were 
exposed to Adenosine (10-4 M), and then to Ca2+-free PSS containing Adenosine (10-4 M) 
and EGTA (2 mM) to obtain maximum passive diameter. A reduction in the maximal 
luminal diameter obtained after the prolonged exposure to DTT was considered evidence 
that inward remodeling had occurred. Presence of cytochalasin-D caused the prolonged 
vasoconstriction induced by DTT to wane over time. Therefore, as both cytochalasin-D 
and cystamine prevented DTT from maintaining vasoconstriction, additional experiments 
were conducted in vessels pressurized to 5 mmHg in order to maintain a reduced 
diameter during the prolonged exposure to DTT in combination with cytochalasin-D or 
cystamine. In all experiments where cytochalasin-D or cystamine was used, arterioles 
were pre-incubated for 20 minutes with the inhibitor and at all times during exposure to 
DTT. 
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Effect of prolonged activation of endogenous transglutaminase on actin 
polymerization  
To determine the effect of prolonged activation of endogenous transglutaminase 
on actin polymerization, we measured the amount of F and G actin present in isolated 
arterioles exposed for 4 hours to DTT or vehicle control as previously described (179) . 
Freshly isolated rat cremasteric 1A arterioles were incubated in 1.5 mL vials at 34°C for 
4 hours in either PSS (Control), or PSS+200µM DTT. Immediately after treatment, 
arterioles were homogenized in an F-actin stabilization buffer (Cytoskeleton #LAS01) 
with ATP, Halt Protease & Phosphatase Inhibitor Cocktail and EDTA (Thermo Scientific 
#78440),. Subsequently, the homogenized samples were centrifuged for 1 hour at 
100,000xg. After centrifugation, the supernatants were transferred into new labeled 1.5 
mL vials, while the pellets were incubated and re-suspended for 1 hour in an F-actin 
depolymerization buffer (Cytoskeleton #FAD02) at 4°C. The supernatant and pellet 
portions of the samples were subjected to SD-PAGE and proteins transferred to 
nitrocellulose membranes (BIO-RAD #162-0147). The blots were probed with rabbit 
polyclonal anti-actin antibody (Cytoskeleton #AAN01 at a 1:1,000 dilution) and protein 
bands visualized with a ChemiDOC XRS+ (BIO-RAD). Images were analyzed and the 
signals for supernatants (G-actin) and pellets (F-actin) for each treatment were quantified, 
and F-actin/Total-Actin ratios were computed and compared (179).     
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Effect of F-actin cytoskeleton disruption on control and remodeled arterioles  
In order to test the effect of F-actin cytoskeleton disruption on the vasculature, 
and to determine the role of F-actin cytoskeletal structures in vascular remodeling, 
freshly isolated arterioles and DTT-remodeled arterioles were subjected to a 1-hour 
incubation with the actin-depolymerizing agent Mycalolide-B (2 µM) in Ca2+-free PSS 
(160, 179). Subsequently, passive pressure-diameter relationships were determined for 
each arteriole.  
 
Determination of arteriolar elastic characteristics  
To study the elastic characteristics of the arteriolar wall, and to determine the 
effect of actin cytoskeleton disruption on remodeled arterioles, pressure-diameter curves 
were obtained under passive conditions (Ca2+-free PSS) before and after every main 
treatment in the experimental protocols. Pressurizations were performed in steps covering 
a range between 5 and 120 mmHg. Maximum internal diameter and wall (left and right) 
thicknesses were recorded at each pressure. This information was later used to determine 
the circumferential stress, strain and moduli of elasticity curves for each group of vessels.   
 
Chemicals  
All chemicals and drugs used in this study were purchased from Sigma (St. Louis, 
Missouri), except for Mycalolide-B, which was acquired from Wako (Wako Chemicals, 
USA, Richmond, Virginia); Alexa Fluor 488 cadaverine from Invitrogen; and the 
chemicals and anti-bodies used for F and G-actin separation were purchased from BIO-
RAD, KPL, Cytoskeleton, Chemicon and Thermo Scientific. In preparation for the 
! 36!
experiments, stock solutions of adenosine, cystamine and DTT were prepared in PSS 
(without Glucose and Pyruvate) at a concentration of 10-2 M, 10-1 M and 10-1 M, 
respectively. Stock solutions of cytochalasin-D and mycalolide-B were made in DMSO at 
a concentration of 1 mM and 2 mM, respectively. Stock solutions were diluted in the 
buffer solution used as superfusate (i.e., PSS or Ca2+-free PSS). The final concentrations 
reported refer to concentrations in the superfusate.  
 
3.2.4 Data analyses 
Data are presented as mean values of multiple experiments (the number of 
experiments is reported for each experimental series in the results section and The 
Figures) ± SEM (standard error of the mean). Diameter (µm), wall thickness (µm), 
pressure (mmHg), circumferential stress (dynes/cm2), strain and modulus of elasticity 
(dynes/cm2) were calculated as previously described (148, 178), and are expressed in 
absolute values. The circumferential stress was calculated at every pressure as 
, where  is the intraluminal pressure,  is the internal diameter; 
and,  and  are the left and right wall thicknesses obtained from the 2D projection 
of the video caliper. The strain was calculated as , where  represents 
the internal diameter measured at the lowest intraluminal pressure (5 mmHg), and Di 
represents the internal diameter measured at greater intraluminal pressures. We calculated 
the modulus of elasticity as the ratio between stress and strain ( ) to obtain a 
measure of the wall stiffness. Repeated measures ANOVA and paired or unpaired T-tests 
were used to make statistical comparisons between means. Differences were considered 
significant at values of P ≤ 0.05. 
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3.3 Results 
 
3.3.1 DTT-induced activation of transglutaminases is blocked by cystamine 
In order to assess the activation of endogenous transglutaminases by DTT, and to 
determine the effectiveness of cystamine to block this activation, we utilized a previously 
described (194) fluorescent assay that quantifies transglutaminase activity by the 
incorporation of transglutaminase substrate Alexa Fluor 488 cadaverine in isolated 
arterioles. The vessels not exposed to DTT had a modest amount of fluorescence 
indicative of minimal incorporation of cadaverine via transglutaminase crosslinking (Fig. 
3.1-A,B). In contrast, DTT treated vessels, displayed a roughly 3-fold increase in 
fluorescent intensity indicative of cadaverine incorporation into arteriolar structures. The 
addition of the transglutaminase inhibitor cystamine (1 mM) completely abolished the 
marked increase in cadaverine incorporation induced by DTT.  
 
3.3.2 Transglutaminase inhibition with cystamine blocks DTT-induced 
arteriolar constriction 
Exposure of isolated and pressurized (60 mmHg) arterioles to DTT induced 
concentration dependent vasoconstriction with a maximal constriction of 43.8±5.8% from 
original spontaneous tone at 10-3 M DTT (n=5).  Inhibition of transglutaminase activity 
with 1 mM cystamine caused vessels to lose 85.7±11.5% of spontaneous myogenic tone 
and prevented DTT at all concentrations up to 200 µM from inducing vasoconstriction 
(n=5) (Fig. 3.1-C). Exposure to cystamine did not prevent a solution containing 80 mM 
KCl from inducing depolarization-dependent vasoconstriction (Fig. 3.1-D).  
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Figure 3.1. Cystamine blocks DTT-dependent activation of endogenous transglutaminases and DTT-
induced vasoconstriction but not depolarization-induced vasoconstriction. A: Confocal images of rat 
cremaster arteriolar walls incubated with Alexa Fluor 488-cadaverine (green) and exposed for 4 hours to 
vehicle control (left), 200 µM DTT (center), or DTT in the presence of 1mM cystamine (right). Blue shows 
smooth muscle nuclei stained with 4',6-diamidino-2-phenylindole (DAPI). B: Mean fluorescence intensity 
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of Alexa Fluor 488 cadaverine in Control (n=5), DTT (n=7), and DTT+Cystamine (n=5) treated arterioles. 
*P≤0.05 vs. Control or DTT+Cystamine. C: Percent control diameter of isolated arterioles exposed to 
incremental concentrations of DTT in the absence (n=5) or presence (n=5) of 1mM cystamine. Diameters 
in the presence of cystamine at DTT 10-6.5 to 10-3.5 M were significantly greater than those with DTT alone 
(*P≤0.05). D: Internal diameter (µm) of isolated and pressurized (60 mmHg) arterioles before (Tone) and 
after exposure to 80 mM KCl in the absence (n=5) or presence (n=5) of 1 mM cystamine. Data are means ± 
SEM. 
 
3.3.3 Prolonged exposure to DTT causes inward eutrophic remodeling in 
isolated arterioles  
Exposure of isolated and pressurized (60 mmHg) arterioles to DTT (200 µM) for 
4 hours caused a strong (39.5±5.1% from spontaneous myogenic tone) and continuous 
(entire exposure time) vasoconstriction (Fig. 3.2-A). Arterioles remained constricted by 
31.8±6.3% of spontaneous myogenic tone after removing DTT from the perfusate for 10 
minutes and by 19.7±8.9% after exposure to the vasodilator adenosine (10-4 M). Once 
arterioles were exposed to Ca2+-free solution, their maximal passive diameter attained 
was significantly smaller and their media-to-lumen ratio significantly larger than those 
observed before exposure to DTT (Fig. 3.2-A,B). Passive pressure-diameter profiles 
obtained before and after exposure to DTT showed that the reduction in inner passive 
diameter was evident at all pressures (Fig. 3.2-C). Strain-stress profiles showed that the 
remodeled arterioles had decreased circumferential stress, but no major changes in 
distensibility (Fig. 3.2-D). Remodeled arterioles had a tendency towards a reduced 
modulus of elasticity at high pressures that was not significantly different (P>0.05) from 
controls (Fig. 3.2-E).   
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Figure 3.2. Prolonged exposure to DTT induces inward remodeling in isolated arterioles. A: 
Arterioles were exposed to 200 µM DTT for 4 hours. Before and after the 4-hour exposure to DTT, 
arterioles were allowed to develop spontaneous tone and subsequently exposed to 10-4 M adenosine (Ado) 
and then to calcium-free solution. Data are means ± SEM of the maximal passive diameter obtained during 
the first exposure to calcium-free conditions. After the second exposure to calcium-free conditions, 
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maximal passive diameter was significantly reduced (*P≤0.05, n=5). B: Wall to lumen ratios of arterioles 
in calcium-free conditions before (Control) and after a prolonged (4-hour) exposure to DTT (n=5). *P≤0.05 
vs. control. C: Passive pressure-diameter curves of arterioles obtained before (Before DTT, n=5) and after 
(After DTT, n=5) exposure (4 hours) to 200 µM DTT. *P≤0.05 vs. Before DTT. D: Passive strain-stress 
relationships of isolated arterioles before (Before DTT, n=5) and after (After DTT, n=5) exposure (4 hours) 
to 200 µM DTT. E: Incremental modulus of elasticity vs. pressure in isolated arterioles under passive 
conditions before (Before DTT, n=5) and after (After DTT, n=5) exposure (4 hours) to 200 µM DTT. F: 
Representative immunoblot of the F- and G-actin portions of the cytoskeleton from arterioles treated with 
vehicle control or DTT (200 µM) for 4 hours. Exposure to DTT increased (P≤0.05) the F/Total actin by 
8.01±3.01 % vs. controls (n=6 for each treatment).  
 
3.3.4 Prolonged exposure to DTT increases the F/Total actin ratio in isolated 
arterioles  
Use of a differential centrifugation assay to quantify F- and G-actin proportions 
revealed that a 4-hour incubation in DTT (200µM) increased the F-actin/Total-actin ratio 
by 8.01% ± 3.01% (n=6) as compared to control arterioles kept in vehicle control for 4 
hours (Fig. 3.2-F).  
 
3.3.5 F-actin disruption does not affect the passive diameter or elastic 
properties of freshly isolated arterioles    
In order to determine the role that disruption of the F-actin cytoskeleton has on 
the elastic characteristics of freshly isolated arterioles, we first confirmed that a one-hour 
incubation in mycalolide-B completely destroyed F-actin fibers in isolated arterioles 
using confocal microscopy. Three-dimensional reconstruction images of arterioles 
exposed for one hour to vehicle control or mycalolide-B stained to visualize F-actin 
fibers with Alexa Phalloidin 546 are shown in Fig. 3.3-A. Notice that incubation with 
mycalolide-B caused a complete obliteration of F-actin fibers contained within cells of 
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the arteriolar wall. In comparison, intact F-actin cytoskeletal structures are evident in 
freshly isolated arterioles exposed to vehicle (Fig. 3.3-A). 
 
Although a one-hour incubation in Mycalolide-B (2 µM) caused complete 
disruption of F-actin fibers in freshly isolated (non-remodeled) arterioles, no significant 
changes in the internal passive diameter or the elastic properties of the vessel wall were 
evident (Fig. 3.3-B-D).  
 
Figure 3.3. Actin cytoskeletal disruption does not affect the passive diameter or elastic 
characteristics of freshly isolated arterioles. A: Three-dimensional confocal images of isolated arterioles 
exposed to vehicle control (left) or 2 µM mycalolide-B (right) and subsequently stained with phalloidin-
Alexa 546 (yellow) to visualize the actin cytoskeleton. B: Pressure-diameter curves of freshly isolated 
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arterioles before (Control, n=7) and after (Control+Mycalolide-B, n=7) exposure (1 hour) to 2 µM 
mycalolide-B. C: Strain-stress relationships of freshly isolated arterioles before (Control, n=7) and after 
(Control+Mycalolide-B, n=7) exposure (1 hour) to 2 µM mycalolide-B.  D: Incremental modulus of 
elasticity vs. pressure in freshly isolated arterioles before (Control, n=7) and after (Control+Mycalolide-B, 
n=7) exposure (1 hour) to 2 µM mycalolide-B. 
 
3.3.6 Disruption of the F-actin cytoskeleton reverts the inward remodeling 
induced by DTT 
The reduction in passive internal diameter induced by prolonged (4 hours) 
exposure to DTT (200 µM) was completely reverted (97.3±7.2%) after mycalolide-B-
induced disruption of the F-actin cytoskeleton. In comparison, exposure to vehicle 
control only partially reversed the DTT-induced inward remodeling by 57.1±8.0%. 
Consequently remodeled arterioles exposed to mycalolide-B had significantly greater 
(P<0.05) passive diameters than those exposed to vehicle control (Fig. 3.4-A,B). Pressure 
diameter curves showed that inwardly remodeled arterioles had greater passive diameters 
after vs. before exposure to mycalolide-B at all pressures in the curve (5-120 mmHg). In 
comparison inwardly remodeled arterioles treated with vehicle control had only greater 
passive diameters at pressures above 20 mmHg (Fig. 3.4-C,D). With regard to the elastic 
properties of the arteriolar wall, exposure of remodeled arterioles to mycalolide-B caused 
reduced distensibility and greater circumferential stress, as well as a 36.7±12.65% 
increase in stiffness (Fig. 3.4-E,G). In comparison, the stress, strain and stiffness of 
remodeled arterioles treated with vehicle control were not significantly affected  (Fig. 
3.4-F,H). 
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Figure 3.4. Disruption of the actin cytoskeleton reverts the inward remodeling caused by 
prolonged exposure of isolated arterioles to DTT. A: Arterioles were exposed to 200 µM DTT for 4 hours. 
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Before and after the 4-hour incubation with DTT, arterioles were allowed to develop spontaneous tone and 
subsequently exposed to 10-4 M adenosine and then to Calcium-free solution. After 5 minutes in the second 
exposure to calcium-free solution, arterioles were exposed for 1 hour to vehicle control (n=6) or 2 µM 
mycalolide-B (n=6). Data are means ± SEM of the maximal passive diameter obtained during the first 
exposure to calcium-free conditions. *P≤0.05 vs. vehicle control.  B: Change in diameter caused by 1-hour 
exposure to mycalolide-B (2 µM) or its vehicle control in arterioles which passive diameter had been 
reduced by a 4-hour exposure to 200 µM DTT. The percent reversal change was significantly greater in 
vessels exposed to mycalolide-B vs. vehicle controls (*P≤0.05). C,D: Pressure-diameter curves of DTT-
inwardly remodeled arterioles before (Remodeled, n=7 in C and n=5 in D) and after exposure (1 hour) to 2 
µM mycalolide-B (Remodeled+Mycalolide-B, n=7) or its vehicle control (Remodeled+Vehicle, n=5). 
*P≤0.05 vs. Remodeled+Mycalolide-B or Remodeled+Vehicle.  E,F: Strain-stress relationships of DTT-
inwardly remodeled arterioles before (Remodeled, n=7 in C and n=5 in D) and after exposure (1 hour) to 2 
µM mycalolide-B (Remodeled+Mycalolide-B, n=7) or its vehicle control (Remodeled+Vehicle, n=5). G,H: 
Incremental modulus of elasticity vs. pressure in DTT-inwardly remodeled arterioles before (Remodeled, 
n=7 in G and n=5 in H) and after exposure (1 hour) to 2 µM mycalolide-B (Remodeled+Mycalolide-B, 
n=7) or its vehicle control (Remodeled+Vehicle, n=5). *P≤0.05 vs. Remodeled+Mycalolide-B. 
 
 
3.3.7 Inhibition of actin polymerization blocks DTT-induced arteriolar 
constriction. 
Exposure of isolated and pressurized (60 mmHg) arterioles to cytochalasin-D 
(500 nM) did not significantly affect vascular tone during the pre-incubation period, but 
over time caused vessels to lose myogenic tone and dilate. Presence of cytochalasin-D 
also prevented DTT at all concentrations used from inducing vasoconstriction (Fig. 3.5-
A).  
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Figure 3.5. Cytochalasin-D inhibits concentration-dependent DTT constriction responses and 
prevents DTT-induced inward remodeling in isolated arterioles. A: Percent control diameter of isolated 
arterioles exposed to incremental concentrations of DTT (n=7) or vehicle control (n=5) in the presence of 
cytochalasin-D (500 nM). B: Arterioles were incubated for 20 minutes with 500 nM cytochalasin-D and 
then exposed to 200 µM DTT for 4 hours in the presence of cytochalasin-D. Before and after the incubation 
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with cytochalasin-D and DTT, arterioles were allowed to develop spontaneous tone and subsequently 
exposed to 10-4 M adenosine and then to Calcium-free solution (n=4). Data are means ± SEM of the 
maximal passive diameter obtained during the first exposure to calcium-free conditions. C: Arterioles with 
intraluminal pressure set at 5mmHg were incubated for 20 minutes with 500 nM cytochalasin-D and then 
exposed to 200 µM DTT for 4 hours in the presence of cytochalasin-D. Before and after the incubation 
with cytochalasin-D and DTT, intraluminal pressure was increased to 60 mmHg and arterioles were 
allowed to develop spontaneous tone followed by exposure to 10-4 M adenosine and then to Calcium-free 
solution (n=6). Data are means ± SEM of the maximal passive diameter obtained during the first exposure 
to calcium-free conditions. D: Passive pressure-diameter curves of arterioles obtained before (Control, n=6) 
and after (DTT+Cytochalasin-D, n=6) exposure (4 hours) to cytochalasin-D (500 nM) and DTT (200 µM), 
while at an intraluminal pressure of 5 mmHg. E: Passive strain-stress relationships of isolated arterioles 
obtained before (Control, n=6) and after (DTT+Cytochalasin-D, n=6) exposure (4 hours) to cytochalasin-D 
(500 nM) and DTT (200 µM), while at an intraluminal pressure of 5 mmHg. F: Incremental modulus of 
elasticity vs. pressure in isolated arterioles under passive conditions obtained before (Control, n=6) and 
after (DTT+Cytochalasin-D, n=6) exposure (4 hours) to cytochalasin-D (500 nM) and DTT (200 µM), 
while at an intraluminal pressure of 5 mmHg.  
 
3.3.8 Inhibition of actin polymerization prevents DTT-induced inward 
remodeling  
In isolated arterioles pressurized to 60 mmHg, presence of cytochalasin-D (500 
nM) inhibited the constriction induced by 200 µM DTT and caused arterioles to dilate 
over the 4-hour exposure to the agents (Fig. 3.5-B). At the end of the prolonged exposure 
to cytochalasin-D and DTT the passive diameter of arterioles did not differ from that 
obtained before exposure to the agents (Fig. 3.5-B). To ensure that vasodilation or the 
lack of constriction (reduction in arteriolar diameter) was not an influencing factor in 
preventing remodeling, an additional series of experiments were performed in arterioles 
maintained at 5 mmHg of intraluminal pressure. In these vessels, exposure to DTT with 
cytochalasin-D for 4 hours caused a small but significant constriction. Nonetheless, DTT 
in the presence of cytochalasin-D failed again to cause a significant reduction in maximal 
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passive diameter measured at 60 mmHg (Fig. 3.5-C). Consequent, no significant changes 
were observed after vs. before the prolonged exposure to DTT and cytochalasin-D in 
pressure-diameter profiles, strain-stress curves and elastic moduli of arterioles (Fig. 3.5-
D-F).  
 
3.3.9 Transglutaminase inhibition with cystamine blocks DTT-induced 
inward remodeling 
Since cystamine also blocked the vasoconstriction induced by DTT, a series of 
experiments were performed in arterioles maintained at 5 mmHg of intraluminal pressure 
to maintain vascular diameter reduced in the presence of cystamine and DTT. In these 
vessels, exposure to DTT with cystamine induced no significant changes in vascular 
diameter (Fig. 3.6-A). In addition, prolonged exposure to these agents caused no 
significant reduction in the maximal passive diameter measured at 60 mmHg (Fig. 3.6-
A,B). No significant changes were observed either in the pressure-diameter profiles, 
strain-stress curves and elastic moduli obtained after the prolonged exposure to DTT and 
cystamine when compared with those obtained before exposure to the agents (Fig. 3.6-B-
D).  
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Figure 3.6. Cystamine prevents DTT from causing inward remodeling in isolated arterioles. A: 
Arterioles with intraluminal pressure set at 5mmHg were incubated for 20 minutes with 1 µM cystamine 
and then exposed to 200 µM DTT for 4 hours in the presence of cystamine. Before and after the incubation 
with cystamine and DTT, intraluminal pressure was increased to 60 mmHg and arterioles were allowed to 
develop spontaneous tone followed by exposure to 10-4 M adenosine and then to Calcium-free solution 
(n=6). Data are means ± SEM of the maximal passive diameter obtained during the first exposure to 
calcium-free conditions. B: Passive pressure-diameter curves of arterioles obtained before (Control, n=6) 
and after (DTT+Cystamine, n=6) exposure (4 hours) to cystamine (1 mM) and DTT (200 µM), while at an 
intraluminal pressure of 5 mmHg. C: Passive strain-stress relationships of isolated arterioles obtained 
before (Control, n=6) and after (DTT+Cystamine, n=6) exposure (4 hours) to cystamine (1 mM) and DTT 
(200 µM), while at an intraluminal pressure of 5 mmHg. D: Incremental modulus of elasticity vs. pressure 
in isolated arterioles under passive conditions obtained before (Control, n=6) and after (DTT+ Cystamine, 
n=6) exposure (4 hours) to cystamine (1 mM) and DTT (200 µM), while at an intraluminal pressure of 5 
mmHg.  
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3.4 Discussion 
 
The primary finding of the present study is that endogenous transglutaminase 
activation with DTT in isolated arterioles induces vasoconstriction and inward 
remodeling that are dependent on actin cytoskeletal dynamics. Based on previous 
publications that indicated DTT induces vasoconstriction in dog coronary arteries (59, 
60) and activation of transglutaminase in mesenteric resistance arteries (194), we first 
confirmed that DTT induced endogenous transglutaminase activation as determined by 
the incorporation of Alexa Fluor cadaverine into  smooth muscle arteriolar structures. 
This cadaverine incorporation induced by DTT was inhibited by the presence of the 
tranglutaminase inhibitor cystamine (Fig. 3.1-A,B). Similar results using a different more 
specific transglutaminase inhibitor (i.e., L682777) have been previously reported (194).  
Our current results, therefore, indicate that in isolated rat-cremaster arterioles, DTT 
induces endogenous smooth muscle transglutaminase activation. 
 
Next, we performed a series of experiments to determine the effect of acute DTT 
exposure on vascular function in isolated cremaster arterioles. DTT caused a 
concentration-dependent vasoconstriction that was completely blocked or diminished by 
the transglutaminase inhibitor, cystamine (Fig. 3.1-C). In comparison, cystamine did not 
block the vasoconstriction induced by membrane depolarization with KCl (Fig. 3.1-D). 
This suggests that DTT induces arteriolar vasoconstriction for the most part through the 
activation of endogenous transglutaminases. The transglutaminases are a group of 
enzymes which primary function is to deamidate, transamidate and crosslink free amine 
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groups with a protein glutamine (62, 137). Of the eight transglutaminases known to exist 
in humans, transglutaminase 1, 2 and 4 have been found in blood vessels, where their 
primary location is within the cytosol of smooth muscle and endothelial cells (14, 91). It 
has been previously shown that the vasoconstriction induced by a number of agonists 
depends on transglutaminase activity (46, 92, 199). Putatively, transglutaminases, in 
particular transglutaminase 2, could exert vasoconstriction via their activity as G proteins, 
as activators of Rho, or via their transamidation process of a number of cytoskeletal 
molecules associated with vascular smooth muscle contraction, including, α actin, 
filamin A and myosin (137, 199). Our results showing that inhibition of actin 
polymerization with cytochalasin-D blocked the constriction induced by increasing 
concentrations of DTT (Fig. 3.5-A), suggest that indeed endogenous transglutaminase 
activation causes vasoconstriction through process that require actin dynamics.  
 
Next, we determined that a prolonged (4-hour) exposure of isolated and 
pressurized arterioles to DTT induced a strong and sustained vasoconstriction that 
resulted in the vessels becoming inwardly remodeled, that is, their maximal passive 
diameter became smaller (Fig. 3.2). We also determined that prolonged exposure to DTT 
induced actin polymerization, as determined by the increased F-actin/Total-actin ratio 
observed in DTT-exposed arterioles compared to controls. Previously we showed that a 
similar 4-hour exposure to the vasoconstrictor agonists norepinephrine and angiotensin-II 
induces inward remodeling in isolated arterioles (115, 179), and that the remodeling 
caused by those vasoconstrictor agonists is reversible upon disruption of the actin 
cytoskeleton (179). Prolonged exposure to vasoconstrictor agonists has also been 
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previously reported to diminish the response of arterioles to adenosine or sodium 
nitroprusside (115).  We have interpreted these reduced responses to endothelium-
independent vasodilators as indication that inward remodeling processes are taking place 
(117). Similarly, in the present study, prolonged exposure to DTT diminished the 
vasodilatory response of arterioles to adenosine, but the mechanisms responsible for this 
effect of prolonged vasoconstriction remains to be determined. 
 
To determine whether the inward remodeling induced by the 4-hour exposure to 
DTT was also dependent on actin cytoskeletal structures, we exposed DTT-remodeled 
arterioles to the actin-depolymerizing agent, mycalolide-B. Actin cytoskeletal disruption 
completely reversed the remodeling induced by DTT (Fig. 3.4-A,B), suggesting that 
changes in actin cytoskeletal structures are responsible for reducing the passive diameter 
of arterioles during the early stages of the inward remodeling process induced by 
transglutaminase activation. The observation that incubation with cytochalasin-D also 
prevented the passive diameter of arterioles exposed for 4 hours to DTT from becoming 
reduced (Fig. 3.5-B,C), further suggests that actin polymerization is needed during the 
inward remodeling process induced by transglutaminase activation. Incubation of 
remodeled arterioles with the vehicle control for mycalolide-B also reversed the 
remodeling induced by DTT, but to a lesser extent than the complete reversal achieved by 
the actin-depolymerizing agent (Fig. 3.4-A,B). We previously reported that the vehicle 
control for mycalolide-B, which contains no calcium and the vasodilator adenosine, does 
not reverse the inward remodeling induced by a 4-hour exposure of isolated arterioles to 
norepinephrine and angiotensin-II (179), suggesting that presence of these 
! 53!
vasoconstrictor agonists causes a more permanent modification of cytoskeletal structures 
than that achieved by the mere DTT-dependent activation of endogenous 
transglutaminases. The observation that the reversal of inward remodeling induced by 
mycalolide-B or its vehicle control differed in their effects on the elastic characteristics of 
the vascular wall further suggests that vasodilation alone reverts only a portion of the 
cytoskeletal changes induced by transglutaminase activation. This is evident by the 
capacity of mycalolide-B to increase the passive diameter of remodeled arterioles even at 
intraluminal pressures of 5 and 10 mmHg (Fig. 3.4-C). Disruption of the actin 
cytoskeleton also reduced the distensibility of remodeled arterioles, and made them stiffer 
(Fig. 3.4-E,G), while vessels exposed to vehicle control had no changes in these 
parameters (Fig. 3.4-F,H). These results support out hypothesis that in the early stages of 
the inward remodeling process induced by prolonged exposure to DTT, changes in the 
actin cytoskeleton are in part responsible for modifying the elastic properties of the 
vascular wall. They are also consistent with data indicating that actin fibers are more 
elastic (pliable) than extracellular matrix structures (191, 192), which more likely 
determine the elastic characteristics of the arterioles after disruption of the actin 
cytoskeleton. 
 
To determine whether the involvement of actin cytoskeletal structures in the 
elastic characteristics of arterioles is only a feature present in remodeled arterioles, we 
compared pressure-diameter curves, strain-stress relationships and elastic moduli of 
freshly isolated arterioles before and after exposure to mycalolide-B (Fig. 3.3). Our 
results indicate that actin cytoskeletal structures have no significant role on the passive 
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elastic characteristics of non-remodeled arterioles, and that involvement of the actin 
cytoskeleton on reducing the passive diameter of arterioles is a common feature in the 
early stages of the inward remodeling induced by direct activation of endogenous 
transglutaminase or exposure to prolonged vasoconstrictor agonists. 
 
Previously, van den Akker et al. (194) reported that exposure of non-pressurized 
resistance arteries to DTT for 24 hours induces inward remodeling through processes 
dependent on the activation of transglutaminase 2. Their data suggest that the reduction in 
passive diameter occurs as extracellular matrix components of the vascular wall are 
crosslinked by transglutaminase activity around a reduced vascular diameter. Because our 
experiments in which DTT was incubated with cytochalasin-D caused vessels to dilate to 
near maximal passive diameter during the 4-hour exposure to the agents, we performed a 
series of experiments in which vessel diameter was maintained reduced at 5 mmHg of 
intravascular pressure during the exposure to DTT with cytochalasin-D (Fig. 3.5-B,C). 
Results from those experiments indicate that inhibition of actin dynamics and not 
vasodilation or the lack of constriction was the reason why vessels did not remodeled 
inwardly. We also performed experiments in which vessels were incubated for 4 hours in 
DTT with the transglutaminase inhibitor cystamine while maintained at 5 mmHg of 
intravascular pressure to keep a reduced vascular diameter (Fig. 3.6). Those vessels also 
failed to remodel inwardly, indicating that indeed endogenous transglutaminase 
activation was responsible for changing actin cytoskeletal structures and reducing the 
passive diameter of arterioles exposed for 4 hours to DTT. Overall, these results suggest 
that in the early stages of the inward remodeling process induced by endogenous 
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transglutaminase activation, reduction of the passive diameter requires changes in actin 
cytoskeletal structures. Our results do not rule out that later on in the remodeling process, 
extracellular transglutaminase activity may solidify the reduced structural diameter of 
vessels by crosslinking extracellular components of the vascular wall. An additional 
potential explanation of our results could be that disruption of actin cytoskeletal 
structures prevents transglutaminase translocation to the cell membrane and extracellular 
environment. However, this is highly unlikely based on our observation that once inward 
remodeling induced by DTT had occurred, it was completely reversed upon actin 
disruption with mycalolide-B. 
 
The physiological relevance of our findings rely on previous reports indicating 
that inhibition of transglutaminase 2 activity blocks or retards the development of inward 
remodeling in resistance arteries exposed to low blood flow (11, 13), and reduces the 
stiffness of conduit arteries that occurs in advanced age (166). The novelty of our 
findings is that changes in vascular structure associated with endogenous 
transglutaminase activation start at the level of the cytoskeleton and not with extracellular 
matrix components. This is particularly important in light of recent reports that indicate 
vascular smooth muscle cellular stiffness plays a more important role in hypertension 
than previously thought (149, 173, 211). Although the methods of activation and 
inhibition of transglutaminase used in our experiments have been used extensively in the 
past (11, 53, 92, 166, 194, 199, 208), a limitation of our study rests on the potential non-
specific effects of DTT and cystamine. Nonetheless, our results are consistent with an 
increasing body of evidence that indicates intracellular transglutaminase activation 
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participates in vascular pathology (21, 36, 124, 165). A better understanding of the 
pathways associated with transglutaminase-dependent cytoskeletal changes should 
provide new therapeutic avenues for controlling vascular remodeling and the adverse 
cardiovascular events associated with it.  
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CHAPTER 4 
FUNCTIONAL AND STRUCTURAL CHARACTERISTICS OF 
SKELETAL MUSCLE AND MESENTERIC RESISTANCE 
ARTERIES FROM OLD SPONTANEOUSLY HYPERTENSIVE 
RATS (SHR) AND WISTAR-KYOTO RATS (WKY) 
 
4.1 Introduction 
 
Hypertension is a chronic medical condition characterized by the presence of 
elevated arterial blood pressure. In most of the cases, hypertension is essential; that is, 
there is no obvious/apparent reason that can be established for the development or 
presence of the disease. Hypertension increases the risk for developing various 
cardiovascular diseases. Cardiovascular diseases are considered the major life threatening 
health conditions. That is why it is important to study and understand all the factors that 
are involved and that play an important role in the development of hypertension; as well, 
as to study and understand the physiological and structural changes that occur in the 
vasculature and are associated with this disease. 
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The spontaneously hypertensive rat (SHR) is the most commonly used animal 
model for the study of cardiovascular diseases associated with essential hypertension. 
These SHRs are Wistar-Kyoto rats that have been bred for high blood pressure. The early 
development of hypertension in SHR starts within the first few weeks of life (5-6 weeks). 
When adult, SHRs can reach systolic pressures of about 180-200 mmHg. These rats 
commonly develop cardiovascular diseases, such as vascular and cardiac hypertrophy, 
after 40 weeks of age.   
 
 In this chapter we focus on the study and understanding of the major functional 
and structural changes associated with essential hypertension and age. A comparison 
between 65-week-old SHRs and WKY rats is presented and the major results are 
discussed.  
 
4.2 Materials and methods 
 
All animal procedures were performed in accordance with the Animal Use and 
Care Committee at the University of Missouri-Columbia and National Institutes of Health 
guidelines. SHRs and Wistar-Kyoto WKY rats 65-week-old were used for the studies 
here included. WKY rats were used as normotensive controls. Animals in both groups 
were maintained in a control (regular rat chow) diet.  
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Rats were anesthetized via an intraperitoneal injection of pentobarbital sodium 
(100 mg/Kg).  After confirmation that spinal reflexes were lost, the mesenteric 
vasculature and both hind legs as well as a portion of the mesentery were excised and 
placed in a cold (~4°C) physiological saline solution (PSS) containing (in mM): 145.0 
NaCl, 4.7 KCl, 2.0 CaCl2, 1.0 MgSO4, 1.2 NaH2PO4, 0.02 EDTA, 2.0 Pyruvic Acid, 5.0 
Glucose and 3.0 3-(N-morpholino) propanesulfonic acid at pH 7.4. Third order (3A) 
mesenteric arterioles (from the mesenteric vasculature) and the gracilis artery (from each 
hind leg) were isolated, cannulated and pressurized for experimentation as previously 
described (32, 33, 115). Experiments were performed at 37°C. After warming up for 
about 1 hour, vessels were exposed to a PSS containing 80 mM KCl to test viability by 
inducing depolarization of vascular smooth muscle cells membranes and vasoconstriction. 
Subsequently, vessels were exposed to increasing concentrations of phenylephrine to test 
for adrenergic vasoconstriction responses. Vasodilation responses to increasing 
concentrations of acetylcholine or sodium nitroprusside (SNP) were performed after 
vessels were pre-constricted with 10-6 M phenylephrine. These agonists tested 
endothelium-dependent and -independent vasodilatory responses, respectively. 
 
To study the elastic characteristics of the arterial wall, pressure-diameter curves 
were obtained under passive conditions (in vessels exposed to Ca2+-free PSS containing 2 
mM ethylene glycol tetra-acetic acid and 10-4 M adenosine) at the end of each experiment. 
Changes in intraluminal pressure were performed in steps covering a range between 5-
120 mmHg. Maximum internal diameter and wall (left and right) thicknesses were 
recorded at each pressure. After experimentation, this information was used to calculate 
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the circumferential stress, strain and modulus of elasticity curves for each group of 
vessels (32, 33). 
 
Post experimentation, vessels were fixed with 4% paraformaldehyde, while 
pressurized at 70 mmHg for 1 hour. For imaging, cannulated vessels were incubated for 1 
hour in 0.5µg/mL 4',6-diamidino-2-phenylindole (DAPI), 0.2µM Alexa Fluor 633 
Hydrazide (Molecular Probes) and 0.02 µM Alexa Fluor 546 phalloidin (Molecular 
Probes) in PBS. Alexa Fluor 633, which stains elastin, was excited with a 633 nm HeNe 
laser. Alexa Fluor 546 phalloidin, which stains the actin cytoskeleton, was excited with a 
543 nm HeNe laser.  DAPI, was used to image nuclei, was excited with a multi-photon 
laser at 700 nm. Second-harmonic image generation was used to image collagen by 
utilizing a multi-photon laser at 850 nM. A Leica SP5 confocal/multiphoton microscope 
with a 63x/1.2 numerical aperture water objective was used to obtain 
confocal/fluorescence images of the vessels under study. Images were processed and all 
channels were quantified to determine the total volume occupied by VSMCs nuclei, 
elastin, actin (within the media) and collagen. The image processing was performed with 
an in-house built algorithm on the MATLAB (The Mathworks, USA) environment. 
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4.3 Results 
 
4.3.1 Adrenergic vasoconstriction responses in arterioles from old WKY and 
SHR are similar 
When assessing adrenergic-receptor dependent vasoconstriction in mesenteric 
arterioles from WKY and SHR rats, no significant differences were found in the 
vasoconstriction levels reached at the different increasing concentrations of 
phenylephrine between groups. Similarly, when gracilis arteries where exposed to the 
same range of increasing concentrations of phenylephrine, the constriction at the 
maximum concentration was not different between groups; however, at low 
concentrations (specifically 10-7 M) gracilis arteries from SHR showed a reduced 
constriction when compared to arteries from WKY (Fig. 4.1). 
 
Figure 4.1. Vasoconstriction measurements at different increasing-concentrations of phenylephrine. 
Values are expressed as a percent of the maximal diameter. Results are given as mean ± SEM. * p<0.05 vs 
WKY.  
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4.3.2 Differences in endothelium-dependent vasodilation for arterioles from 
WKY and SHR 
Endothelium-dependent vasodilation was assessed on gracilis and mesenteric 
arterioles by exposure to increasing concentrations of acetylcholine. Although, no 
significant differences were observed in maximal dilation in either of the two vascular 
beds between groups (Fig. 4.2), the EC50s associated with the vasodilatory respectively 
dose-response for mesenteric arterioles from WKY rats and SHRs were significantly 
different. EC50s were calculated at -7.891±0.016 for WKY and -6.995±0.199 for SHR 
(Fig. 4.2-A). 
 
 
Figure 4.2. Endothelium-dependent vasodilation at different increasing-concentrations of 
acetylcholine. Relaxation is expressed as percent dilation from the constriction level at phenylephrine      
10-6 M. Results are given as mean ± SEM.  
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4.3.3 Mesenteric arterioles from SHRs have heightened SNP-vasodilation  
When exposing mesenteric arterioles to increasing concentrations of the 
endothelium-independent vasodilator SNP, arterioles from SHR showed an increased 
relaxation (p<0.05) at every concentration compared to arterioles from WKY (Fig. 4.3-A). 
No significant differences in the dilation induced by SNP in gracilis arteries were 
observed between groups (Fig. 4.3-B). 
 
 
Figure 4.3. SNP vasodilation at different concentrations ranging from 10-8 to 10-4 M. Values are 
expressed as percent dilation from the constriction level at phenylephrine 10-6 M. Results are given as mean 
± SEM. * p<0.05 vs WKY. 
 
4.3.4 Arterioles from SHRs are inwardly remodeled 
Mesenteric and gracilis arterioles from SHRs showed significantly reduced 
(p<0.05) luminal diameters under passive conditions when compared with the control 
group (WKY). The arterioles from SHRs also had significantly larger wall-to-lumen 
ratios. These are both structural markers indicative of inward remodeling (Fig. 4.4). 
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Figure 4.4. (A, B) Characterization of the maximum passive luminal diameter at different 
intraluminal pressures for mesenteric and gracilis arteries from WKY and SHRs. (C, D) Wall-to-lumen 
ratios at every pressure for mesenterics and gracilis arterioles, respectively. Results represent means ± SEM. 
* p<0.05 vs WKY. 
 
4.3.5 Arterioles from SHRs have reduced compliance indicative of increased 
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stiffness, as a function of intraluminal pressure showed that, in the lower range of 
pressure, arterioles from SHR had significantly reduced compliance, which is indicative 
of increased stiffness.  (Fig. 4.5-C,D). 
 
Figure 4.5. Assessment of elastic properties of arterioles obtained from WKY and SHRs. Panels A 
and B show the calculated Stress as function of the Strain. The cross-sectional compliance as a function of 
pressure is shown in panels C and D. Values represent means ± SEM. * p<0.05 vs WKY. 
 
4.3.6 Arterioles from SHRs have increased media thickness, medial cross-
sectional area and number of smooth muscle cells 
Analysis of the structural modifications occurring in arterioles from SHRs, via 
fluorescence and confocal microscopy, showed that vessels from these rats have a 
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significantly larger gap between their internal and external elastic laminas (media 
thickness) (Fig. 4.6-A). The cross-sectional area associated with the media was 
significantly increased in SHR, indicative of hypertrophic remodeling of the vascular 
wall (Fig. 4.6-B). When quantifying the number of nuclei associated with vascular 
smooth muscle cells, arterioles from SHR had a significantly increased number of nuclei, 
indicative of these arterioles undergoing hyperplasia (Fig. 4.6-C).  
 
Figure 4.6. (A) Media thickness. These values represent the measured distance from the internal 
elastic lamina to the external. These measurements were performed on elastin stained vessels imaged by 
confocal microscopy. (B) Cross-sectional area associated with the media layer of the vascular wall. (C) 
Number of vascular smooth muscle nuclei within a region of interest. Values represent means ± SEM.        
* p<0.05 vs WKY. 
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4.3.7 Arterioles from SHRs have smaller fenestrae in their internal elastic 
lamina  
Characterization of the elastic laminas in arterioles from SHRs and WKY rats 
showed that the fenestrae present in both mesenteric  (Fig. 4.7-A) and gracilis  (Fig. 4.7-
B) resistance arteries from SHRs are significantly smaller in size.  
 
 
Figure 4.7. Mean size per fenestrae in mesenteric (A) and gracilis (B) arteries from SHRs and 
WKY rats. Results are given as means ± SEM. * p<0.05 vs WKY. 
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vessels from SHRs showed a tendency to present a reduced constriction to phenylephrine 
at lower concentrations. This suggests that adrenergic vasoconstrictor pathways are 
impaired in old rats with essential hypertension. This effect was more evident in gracilis 
arteries, where the difference in constrictions reached a significant level at a 
phenylephrine concentration of 10-7 M. Endothelium-dependent dilation assessed via 
exposure to a range of increasing concentrations of acetylcholine showed similar 
dilations for both groups and in both vascular beds under study. SNP is an endothelium-
independent vasodilator, the pathways through which SNP induces dilation are not all 
completely understood; however, it is primarily considered a NO donor (1, 87, 95, 147, 
172). SNP, therefore, acts directly on the smooth muscle cells. Our results suggest that in 
adult normotensive aged rats, some of the pathways through which SNP induces dilation 
are affected, decreasing the sensitivity for NO. This loss in sensitivity is not present in 
SHRs. Mesenteric and gracilis arteries from SHRs had a significantly smaller luminal 
diameters with increased wall thickness, increased wall-to-lumen and increased cross-
sectional area associated with the media layer of the vascular wall. These observation are 
indicative of inward hypertrophic remodeling of the resistance arteries. The number of 
nuclei was also increased in the SHR model, indicative of hyperplasia. In the low range 
of intraluminal pressures, the cross-sectional compliance, which is inversely proportional 
to the stiffness, was significantly reduced in arterioles from spontaneously hypertensive 
rats. These are all common findings in essential hypertension and major predictors for 
cardiovascular diseases.  
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CHAPTER 5 
DIET-INDUCED OBESITY IS ASSOCIATED WITH AUGMENTED 
ELASTIN CONTENT AND INCREASED STIFFNESS OF 
MESENTERIC RESISTANCE ARTERIES IN MICE 
 
5.1 Introduction 
 
Consumption of a western diet (WD), high in fat and sugar, has led to a dramatic 
increase in the prevalence of obesity (body mass index ≥ 30 kg/m2) over the last decades 
in the US, and worldwide (45, 145). Obesity is associated with impaired cardiovascular 
function and is a risk factor for a range of pathologies including hypertension, 
atherosclerosis, and type II diabetes (7, 63, 126). Consumption of excess nutrients and 
associated overweight/obesity is also linked with increased cardiovascular stiffness. In 
mice, we recently reported that consumption of a WD caused cardiac fibrosis and 
diastolic dysfunction (26). Using aortic pulse wave velocity as a measurement of arterial 
stiffness, others have shown that abdominal body fat is positively correlated with a faster 
pulse wave, indicative of stiffer arteries (184). Additional studies have also found a 
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positive correlation between body mass index and pulse wave velocity, suggesting there 
is an association between obesity and arterial stiffening (113, 186, 187, 203). 
 
Arterial stiffening is characterized by a reduction in the ability of an artery to 
expand and contract in response to luminal pressure changes (32). This stiffening causes 
a decreased level of distensibility at a given pressure that has important pathological 
implications, as a number of cardiovascular diseases are associated with increased 
stiffness in conduit and coronary arteries, including hypertension (146, 197) and 
atherosclerosis (52, 195). Arterial stiffness is also prevalent in type II diabetes, where the 
subsequent development of cardiovascular disease is the main cause of death (83, 180). 
The mechanism(s) leading to arterial stiffness have not been fully elucidated, in particular 
at the level of the microcirculation, where the majority of resistance to blood flow occurs. 
Moreover, it is unclear whether arterial stiffening is a maladaptive process in response to 
a disease state, or whether it precedes cardiovascular disease and plays a causative role in 
initiating cardiovascular dysfunction. In the case of hypertension, recent data suggests the 
latter. In a longitudinal study, arterial stiffening was associated with a higher risk for 
developing hypertension, in contrast, initial blood pressure was not a risk factor for the 
subsequent development of arterial stiffness in subjects four to ten years later (93). In a 
mouse model for WD-induced obesity, it was demonstrated that aortic stiffening precedes 
systolic hypertension (200). We have previously reported that there is a marginal increase 
in systolic blood pressure in mice fed a WD (134), however it is not known whether this 
increase is associated with changes in function and/or stiffness at the level of the 
resistance vasculature. 
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One of the mechanisms proposed to initiate arterial stiffening is a change in the 
structural organization of the extracellular matrix (ECM) within the arterial wall. Elastin 
and collagen fibers are the main structural ECM components of the vascular wall. Elastin 
in particular is the most abundant ECM in vascular elastic laminas. It allows the vessel to 
expand and return to its original diameter in response to pressure changes. In the 
resistance arteries of rodents, the internal elastic lamina (IEL) is an intact sheet perforated 
with holes, termed fenestrae. These openings provide portals for communication between 
the endothelium and vascular smooth muscle cells (VSMCs) via direct cell-cell 
membrane contacts (108) or through the diffusion of vasoactive agents. It was 
demonstrated that the size of these fenestrae as well as their number are reduced in 
inwardly remodeled vessels from angiotensin-II treated rodents, and this coincided with 
an increase in mesenteric arterial stiffness and the development of hypertension in rats 
(28). In a pig model of atherosclerosis, the number of fenestrae was also decreased in 
atherosclerotic coronary arteries (106). Together these observations suggest that dynamic 
changes to the fenestration of the IEL could be an early structural modification and lead 
to the subsequent development of cardiovascular disease. The goal of this study was to 
determine if a WD, linked to the rising incidence of obesity and hypertension, induces 
functional changes and/or structural remodeling of the ECM in resistance arteries. A 
second goal was to identify potential triggering mechanism(s) for the development of 
arterial stiffness and cardiovascular disease associated with obesity. 
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5.2 Materials and methods 
 
5.2.1 Animal care and use 
All animal procedures were performed in accordance with the Animal Use and 
Care Committee at the University of Missouri-Columbia and National Institutes of Health 
guidelines. C57BL6/J males were obtained from The Jackson Laboratory. Groups of 4-
week-old male mice were fed a WD (TestDiet 5APC, Test Diet, St. Louis, MO) 
consisting of high fat (46%) and high carbohydrate as sucrose (17.5%) and high-fructose 
corn syrup (17.5%) for 16 weeks (134). A parallel group of age-matched male controls 
were fed a normal diet (ND), i.e. regular mouse chow, for the same time (TestDiet 5APD, 
Test Diet, St. Louis, MO). Both cohorts were provided water ad libitum while housed in 
pairs under a 12-hour/day illumination regimen. 
 
5.2.2 Vessel isolation and functional assessments 
Mice were anesthetized by isoflurane inhalation. After confirmation that spinal 
reflexes were lost, the mesenteric vasculature was excised and placed in a cold (~4°C) 
physiological saline solution (PSS) containing (in mM): 145.0 NaCl, 4.7 KCl, 2.0 CaCl2, 
1.0 MgSO4, 1.2 NaH2PO4, 0.02 EDTA, 2.0 Pyruvic Acid, 5.0 Glucose and 3.0 3-(N-
morpholino) propanesulfonic acid at pH 7.4. First order (1A) feed mesenteric arteries 
were isolated, cannulated and pressurized for experimentation as previously described 
(115). Briefly, arteriolar segments of ~3mm in length were cannulated onto glass 
micropipettes within an observation chamber (Living Systems Instrumentation, 
Burlington, Vermont) filled with PSS. The arteries were pressurized without flow to 70 
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mmHg using a Pressure Servo System (Living Systems Instrumentation Burlington, 
Vermont) and PSS containing 0.15 mM bovine serum albumin. The chamber was 
transferred to an inverted microscope equipped with a videodisplay and video caliper 
(Living Systems Instrumentation Burlington, Vermont) to record vascular wall thickness 
and luminal diameter. All experiments were performed at 37°C. Warmed vessels were 
exposed to PSS containing 80 mM KCl equimolarly substituted for NaCl to induce 
depolarization and vasoconstriction and test viability. Subsequently, vessels were 
exposed to increasing concentrations of phenylephrine to test for adrenergic 
vasoconstriction responses. Vasodilation responses to increasing concentrations of insulin 
or sodium nitroprusside (SNP) were performed after vessels were pre-constricted with  
10-6 M phenylephrine. Responses are reported as percent of maximal constriction, percent 
reduction in maximal passive diameter, or as percent of phenylephrine pre-constriction. 
Maximal passive diameter was obtained at the end of each experiment by exposing 
vessels to Ca+2-free PSS in the presence of 2 mM ethylene glycol tetra-acetic acid and  
10-4 M adenosine. 
 
5.2.3 Determination of arterial elastic characteristics 
To study the elastic characteristics of the arterial wall, pressure-diameter curves 
were obtained under passive conditions (Ca2+-free PSS) at the end of each experiment. 
Changes in intraluminal pressure were performed in steps covering a range between 5-
120 mmHg. Maximum internal diameter and wall (left and right) thicknesses were 
recorded at each pressure. This information was used to determine the circumferential 
stress, strain and modulus of elasticity curves for each group of vessels. 
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5.2.4 Confocal/multiphoton fluorescence microscopy imaging 
At the end of each experiment, vessels were fixed with 4% paraformaldehyde, 
while pressurized at 70 mmHg for 1 hour. For imaging, vessels were rinsed twice in 
phosphate buffered saline (PBS) and once in 0.1M Glycine for 5 minutes each time. 
Cannulated vessels were flushed with 1 mL PBS to rinse their lumen, and permeabilized 
via incubation in 0.5% TritonX100 for 20 minutes. Vessels were washed twice in PBS 
and incubated for 1 hour in 0.5µg/mL 4',6-diamidino-2-phenylindole (DAPI), 0.2µM 
Alexa Fluor 633 Hydrazide (Molecular Probes) and 0.02 µM Alexa Fluor 546 phalloidin 
(Molecular Probes) in PBS. After being washed 3 times in PBS, vessels were imaged 
using a Leica SP5 confocal/multiphoton microscope with a 63x/1.2 numerical aperture 
water objective. Alexa Fluor 633, to image elastin, was excited with a 633 nm HeNe laser. 
Alexa Fluor 546 phalloidin, to image actin components, was excited with a 543 nm HeNe 
laser.  DAPI, to image nuclei, was excited with a multi-photon laser at 720 nm. Collagen 
was imaged via second-harmonic image generation using a multi-photon laser at 850 nM.  
 
5.2.5 Image processing 
Images were processed and all channels were quantified to determine the total 
volume occupied by VSMCs nuclei, elastin, actin (within the media) and collagen. The 
image processing was performed with an in-house built algorithm on the MATLAB (The 
Mathworks, USA) environment. The four channels corresponding to Elastin, Actin, 
Nuclei and Collagen were saved as individual slices that formed 3D data sets.  
First, the Elastin channel was processed to estimate the boundaries of the vessel. Pre-
processing of the data was required to reduce the noise. Each slice of the 3D data set was 
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reduced in dimensions with a standard Quad Tree averaging: the intensities of a four 
neighboring elements were averaged and assigned to a new image (61). In this way, the 
noise is reduced at the expense of a reduced spatial resolution. The reduction was carried 
out twice, therefore subsequent calculations were performed on data sets with 256 × 256 
pixels as the channels consisted of images with 1024 × 1024 pixels. In order to estimate 
the boundaries of the Elastin, it was assumed that the Elastin fibers formed half a cylinder, 
which was “stretched out” to a planar form by transforming between Cartesian and Polar 
coordinates. Once stretched; the boundaries were assumed to be at the two peaks of 
maximum intensity over each column, and then these points were translated back to the 
Cartesian coordinates. The two boundaries were returned to the original dimensions of 
1024 × 1024 to be used to quantify the expression of the other channels relative to the 
position of the boundaries. 
 
Since the intensity levels of the pixels from the DAPI channel varied considerably, 
the intensity segmentation with a single threshold would have merged some of the bright 
regions, which corresponded to two separate nuclei, while discarding the dim nuclei. To 
prevent this, the segmentation was performed in 2 stages, first with a high threshold to 
detect the bright regions, then with a low threshold to detect faint regions. In addition, to 
improve the segmentation, a hysteresis thresholding was used for both bright and dim 
Nuclei. Hysteresis thresholding (73) uses a double threshold in the following way; pixels 
below a low threshold are considered as background and pixels above the high threshold 
are considered as nuclei. Pixels in between the two thresholds are considered as nuclei 
only if they are in contact with pixels above the high threshold. The thresholds of all 
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slices were derived from the threshold levels calculated with the algorithm proposed by 
Otsu (143). A final post-processing stage was to remove all nuclei with a predetermined 
volume of 15 voxels. 
 
The regional quantification of expression of the proteins was calculated in the 
following way: images of each channel were segmented with a single threshold. The total 
number of segmented voxels was counted, as well as number of segmented voxels that 
were located within the two boundaries of the Elastin. From these values, the relative 
expression for each channel was calculated. Figure 5.1 shows the results of the 
segmentation process. The Elastin Boundaries are displayed as two surfaces with 
different shades of gray, the locations where the expression was located is shown in 
different colors. The Nuclei were divided in three groups and counted relative to their 
location with the boundaries: (a) in contact with the boundaries, (b) in between the two 
boundaries, (c) outside the boundaries. These classifications are indicated by different 
colors in Figure 5.1 (c). 
 
In a separate analysis, for the DAPI and Alexa 633 channels, a region of interest 
(ROI) was selected (95 µm x 143 µm for DAPI and 60 µm x 121 µm for Alexa 633) and 
the total number of nuclei and fenestrae were calculated using an Image-J macro. 
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Figure 5.1. Representative processing of a mouse mesenteric resistance artery image. 
Segmentation of four channels was used to quantify the expression of four different proteins: (a) Actin, (b) 
Elastin, (c) Nuclei, (d) Collagen. The boundaries of elastin are shown in gray, the inner in a darker shade 
than the outer boundary. The nuclei were classified according to their location relative to the boundaries; 
purple is outside the boundaries, blue is in contact with the boundaries and cyan is in between the two 
boundaries. To aid the visualization, the outer boundary has been retracted as well as the components. The 
inner boundary is shown complete. 
 
5.2.6 Assessment of insulin resistance 
Glucose and Insulin levels were determined as previously described (210). Briefly, 
venous blood was drawn from fasting mice and assessed for glucose concentrations using 
a G-6-PDH assay, and insulin levels with a mouse specific Elisa. Insulin resistance was 
calculated using the homeostasis model assessment (HOMA-IR) formula: HOMA-IR = 
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fasting glucose (mg/dL) × fasting insulin (µU/ml)/405 (125). HOMA-IR has been shown 
to be strongly correlated with the insulin sensitivity index derived from the standard 
euglycemic hyperinsulinemic clamp method (54). In the HOMA-IR model, insulin levels 
are expressed in international units. Within the literature, there is a discrepancy on the 
concentration of insulin that equals 1 µU activity (72). We used the potency factor 
(28,698 U/g) provided by the manufacturer of Novolin R (Novo-Nordisk), thus the 
conversion from mass units to units of activity was 6.00 ρmol/l = 1µU/ml. 
 
5.2.7 Real-time quantitative PCR 
Total RNA was extracted from mesenteric arteries using Arcturus PicoPure RNA 
Isolation Kit (Life Technologies, Carlsbad, CA, USA), equal amounts of total RNA 
extracts were then reverse transcribed to generate cDNAs using SuperScipt III First-
Strand Synthesis System (Life Technologies). Real time TaqMan PCR assays were 
performed using a Mastercycler EP Realplex2 (Eppendorf-North America, Westbury, NY, 
USA) and TaqMan Fast Advanced Master Mix (Life Technologies). Probes and primers 
for amplification of elastin and the housekeeping gene, β-2-microglobulin, were 
purchased from Life technologies (Mm00514670_m1 for elastin, Mm01178820 for TGF-
β1, Mm00437762_m1 for β-2-microglobulin). Reactions were performed in 20 µl, 
comprised of 10 µl master mix, 1 µl probe and primers, 1 µl of cDNA template and 8 µl 
DNase-free water. Thermal cycling conditions were as follows: 50oC for 2 min, 95oC for 
20 sec, repeat for 40 cycles of 95oC for 3 sec and 60oC for 30 sec. Realplex software 
(Eppendorf-North America) was used to collect and analyze the data. The following 
equation was used to determine the relative mRNA expression level (R) for Elastin or 
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TGF-β1 normalized to β-2-microglobulin expression: R= 2−ΔΔCt = 2−(ΔCt elastin - ΔCt β-2-
microglobulin) as previously described (111, 119).  
 
5.2.8 Protein expression 
Aortas were isolated from mice, and homogenized with a bead rupture (Omni 
Bead Ruptor, Omni International, Keenesaw, GA) in 200 µl radio-immunoprecipitation 
lysis buffer containing HALT Protease Inhibitor Cocktail (Pierce, Thermo Scientific, 
Rockford IL). Homogenates were centrifuged (13,000 × g for 10 min at 4°C) to remove 
debris. Protein content was determined with a BCA Protein Assay Kit (Pierce). Protein 
extracts (12 µg) were heated at 94°C for 5 minutes, separated on a 10% gel, and 
transferred to a nitrocellulose membrane. The blot was blocked for 45 minutes at room 
temperature in 0.5% Tween 20 Tris-buffered saline + 5% milk. Membranes were 
incubated over night at 4 °C with anti-TGF-β 1-2-3 at 1:500 dilution and subsequently 
with horseradish peroxidase-conjugated secondary antibody (1:10,000; room temperature 
for 2 hours). Stripped membranes were re-probed with an antibody specific to β-actin for 
normalization. For TGF-β, peroxidase activity was visualized with the Super Signal West 
Femto (Pierce) and LumiGlo (KPL, Baltimore, MD) for β-actin. Signal was visualized 
using a Bio-Rad Chemi-Doc Imaging System. TGF-β and β-actin protein bands were 
quantified using the Bio-Rad Chemi-Doc software. Results are expressed as a ratio of 
TGF-β to β-actin. 
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5.2.9 Data analyses 
Data are expressed as means ± SEM. The number of experiments represents the 
number of animals in each experimental group. Statistical analyses included T-test, or 
ANOVA followed by Bonferroni post hoc test where appropriate. A value of P<0.05 was 
considered significant. All statistical analyses were performed using GraphPad Prism 5 
software. 
 
5.3 Results 
 
5.3.1 Feeding a western-diet induced significant weight gain, increased 
plasma insulin levels and caused insulin resistance 
Feeding mice a WD high in fat and sugar for 16 weeks after weaning resulted in 
substantial weight gain compared to mice fed a ND. The average body weight of 20 
week-old WD-fed mice was significantly greater (P<0.05) than that of mice fed a ND 
(Fig. 5.2-A). In addition, there was a significant increase (P<0.05) in fasting plasma 
insulin levels in the WD cohort (Fig. 5.2-B), which in turn resulted in insulin resistance 
as assessed by HOMA-IR (Fig. 5.2-C). Plasma glucose levels were not significantly 
different between the two cohorts (data not shown). 
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Figure 5.2. Mice fed a WD were significantly heavier than ND-fed mice and had elevated fasting 
insulin levels. (A) Mean body weights of control ND-fed mice  (n=9) and WD-fed mice (n=10). Mean body 
weight was greater in WD-fed mice, *P< 0.05. (B) Plasma concentration of insulin from mice following 4 
hrs of fasting, was significantly elevated in mice fed a WD (n=10) vs. control mice fed a ND (n=10), 
*P<0.05. (C) HOMA-IR (fasting glucose ((mg/dL x fasting insulin uU/ml)/405) index was significantly 
higher for WD-fed mice (n=10) vs. control mice fed a ND (n=10), *P<0.05. Data are means ± SEM. 
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5.3.2 Western-diet did not affect receptor-dependent or receptor-
independent vasoconstriction 
To assess if the WD affected vascular α1-adrenergic receptor activation, isolated 
mesenteric arteries were exposed to increasing concentrations of phenylephrine (10-8 M – 
10-4 M). There was not a statistically significant difference in percent maximum 
constriction between arteries from WD- and CD-fed mice, or in the half maximal 
effective concentration for the drug (Fig. 5.3-A). To determine if receptor-independent 
vasoconstriction was affected by the WD, we exposed isolated arteries to 80 mM KCl. 
Depolarization-induced vasoconstriction with high K+ was not statistically different 
between WD and CD mice (Fig. 5.3-B). 
 
 5.3.3 Western-diet reduced basal myogenic tone in mesenteric resistance 
arteries 
Mesenteric arteries from mice fed the WD had a decreased level of spontaneous 
myogenic tone compared to arteries from mice fed the ND. The arteries from WD-fed 
mice developed tone at 88.62 ± 2.04% of maximal passive diameter vs. 79.50 ± 2.42% of 
the ND-fed mice (P<0.05) (Fig. 5.4). 
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Figure 5.3. Constriction to adrenergic stimulation was unaffected by a WD. (A) Vessels were 
allowed to develop tone, and maximum passive diameter was determined in Ca2+ -free PSS. Vessels were 
exposed to increasing concentrations of phenylephrine and arterial diameter was assessed and expressed as 
a percent of basal myogenic tone. (B) Vessels, from A, were assessed for constriction to KCl (80 mM) and 
constriction expressed as percent maximal constriction ((Maximal passive diameter–Diameter at 80 mM 
KCL)/(Maximal passive diameter)) x 100). Data are means ± SEM, Control (n=9), Obese (n=10).  
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Figure 5.4. Effect of WD on Myogenic tone. Basal myogenic tone expressed as percent reduction in 
maximal passive diameter. Comparisons are between control ND-fed mice (n=9) and WD-fed mice (n=10).  
Data are means ± SEM. *P<0.05 vs. control 
 
5.3.4 Effect of diet-induced obesity on vasodilatory signaling pathways 
As illustrated in Figure 3C, the WD cohort was insulin resistant. In obese human 
subjects, insulin resistance is associated with an impaired vasodilatory response to insulin 
in peripheral arteries (185). To determine if the WD-fed mice had an impaired 
vasodilatory response to insulin, isolated mesenteric arteries were pre-constricted with 
10-6 M phenylephrine and exposed to increasing concentrations (10-9 – 10-5 M) of insulin. 
There was no significant difference in the insulin-induced dilation for arteries from WD-
fed mice vs. the ND-fed cohort (Fig. 5.5-A). To assess if endothelium-independent 
relaxation pathways were affected by the WD, pre-constricted vessels were exposed to 
increasing concentrations (10-8 - 10-4 M) of SNP. There was not a significant difference 
between the two groups for SNP induced vasodilation (Fig. 5.5-B). At low concentrations 
of both insulin and SNP, vessels from CD-fed mice had a tendency to relax better than 
those from WD-fed mice, but the differences were not significant (P=0.06). 
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Figure 5.5. Effect of a WD on vasodilation to receptor-dependent and receptor-independent 
agonists. Mesenteric arteries from control ND-fed mice (n=9) and WD-fed mice (n=10) were pre-
constricted with 10-6 M phenylephrine, and their internal diameters assessed in the presence of increasing 
concentrations of (A) insulin and (B) SNP. Data are means ± SEM, and expressed as percent constriction to 
10-6 M phenylephrine. 
 
5.3.5 Effects of a western-diet on the structure and elastic properties of 
resistance arteries 
Obese individuals have been shown to have increased arterial stiffness (increased 
pulse wave velocity). Moreover, in the same strain of mice used in this study, aortic 
stiffness had been shown to be increased after 1 month of exposure to a WD (200). To 
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determine if the WD also affects the stiffness of resistance vessels, we examined the 
elastic properties of mesenteric arteries from the WD- and ND-fed mice under passive 
conditions. There were no significant differences in wall stress as a function of strain in 
vessels from WD- vs. ND-fed mice. However there was a not significant (P=0.07) 
tendency for arteries from the WD-fed mice to have greater stress at the highest levels of 
strain (Fig. 5.6-A). This in combination with a tendency for the arteries from the WD-fed 
mice to be less distensible (reduced strain) resulted in these arteries being stiffer, that is 
they had a greater (P<0.05) modulus of elasticity than vessels from the ND-fed mice (Fig. 
5.6-B). 
 
 
Figure 5.6. Stress strain characteristics of ND and WD cohorts. (A) Strain-stress relationship 
curves of mesenteric arteries from control ND-fed mice (n = 9) and WD-fed mice (n = 10). (B) Incremental 
modulus of elasticity vs. pressure from the same set of arteries in panel A. *P<0.05 vs. control. 
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5.3.6 Effect of a western-diet on resistance artery remodeling 
To assess vascular remodeling, we obtained pressure-diameter curves in isolated 
vessels under passive conditions and also calculated wall area to lumen ratios. No 
differences in the pressure-diameter curves were observed between arteries from the WD- 
vs. the ND-fed mice at any pressure (Fig. 5.7-A). No significant differences in 
wall/lumen ratios were found either. However, there was a not significant tendency 
(P=0.08) for the WD-fed cohort to have lower ratios (Fig. 5.7-B). Because our wall 
thickness measurements do not take into account cellularity, we fixed the isolated 
arterioles and stained with DAPI to identify VSMC nuclei and with phalloidin to measure 
actin content in the vascular media. There were no significant differences in the number 
of VSMC nuclei or actin content in the media from mesenteric arteries derived from the 
WD-fed vs. the ND-fed mice. 
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Figures 5.7. Effect of a WD on passive diameters and media to lumen ratios of mesenteric 
resistance arteries. (A) Internal passive (Ca2+ -free PSS) diameters obtained at different intravascular 
pressures in mesenteric resistance arteries isolated from mice fed either a control diet (n=9) or a western 
diet (WD, n=10). Data are means ± SEM. (B) Comparison of mean media to lumen ratios for mesenteric 
arteries from control ND-fed mice (n = 9) and WD-fed mice (n = 10). Data are means ± SEM. 
Measurements were made at 70mmHg in Ca2+ -free PSS. 
 
5.3.7 Effect of a western-diet on collagen and the internal elastic lamina 
Mesenteric arteries from WD- and ND-fed mice were isolated, fixed and stained 
for elastin, actin and nuclei (Fig. 5.8-A-D). Alexa633 was used to visualize the internal 
elastic lamina (Fig. 5.8-B). Staining with elastin specific antibodies revealed the same 
staining pattern as Alexa633 ((41) and data not shown).  The volume occupied by 
Alexa633 fluorescence was greater in vessels from WD- vs. ND-fed mice (P<0.05), 
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indicating an increase in elastin volume for the WD cohort (Fig. 5.8-F). Collagen, actin 
and nuclei were imaged concomitantly using multiphoton second-harmonic image 
generation, phalloidin and DAPI, respectively. There was not a significant difference in 
the amount of collagen, actin, or nuclei between the two groups, nor was there a 
difference in the actin to nuclei ratio (Fig. 5.8-E,G,H,J). The elastin to collagen ratio was 
also calculated, and was significantly higher for the WD cohort (Fig. 5.8-I). The number 
of fenestrae present in the IEL for each group was also determined. Mesenteric arteries 
from mice fed the WD had significantly (P<0.05) less fenestrae per unit area than vessels 
from the ND-fed mice (Fig. 5.9-A,B). The average size of each fenestra was not 
significantly different between the groups, but there was a shift in the distribution of 
fenestrae size towards smaller diameters (~1 µm2) in vessels from the WD-fed mice as 
assessed by the Gaussian distribution of fenestrae sizes (Fig. 5.9-C). Overall, the 
fenestrae total area was also significantly greater (P<0.05) in the WD vs. the ND group 
(Fig. 5.9-D).  
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Figure 5.8. Effect of a WD on the ECM of mesenteric artery structure. Mesenteric arteries from 
both diet cohorts were imaged for nuclei, elastin, actin and collagen. Representative image of a vessel with 
(A) DAPI to image nuclei, (B) Alexa633 to image elastin, (C) phalloidin to image actin and (D) second 
harmonics to image collagen, scale bar = 30µm. (E) Comparison of mean number of voxels containing 
DAPI fluorescence above threshold for mesenteric arteries from control and WD-fed mice, (F) Comparison 
of mean number of voxels containing Alexa633 fluorescence above threshold, (G) Comparison of mean 
number of voxels containing second harmonic fluorescence above threshold, (H) Comparison of mean 
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number of voxels containing phalloidin 546 fluorescence above threshold, (I) Comparison of the ratio of 
the number of voxels containing elastin fluorescence above threshold vs. the number of voxels containing 
collagen fluorescence above threshold for the control ND and WD cohorts. *P<0.05 vs, control. (J) 
Comparison of the ratio of the number of voxels containing actin fluorescence above threshold vs. the 
number of voxels containing DAPI fluorescence above threshold for the control ND and WD cohorts. For 
panels E-J, ND (n = 9) and WD (n = 10). Data are means ± SEM. 
 
 
Figure 5.9. Effect of a WD on IEL fenestrae. (A) Representative image of elastin staining with 
fenestrae readily discernible in mesenteric resistance arteries from a control ND-fed mouse and a WD-fed 
mouse. (B) Comparison of the mean number of fenestra per unit area in mesenteric arteries isolated from 
control ND- (n = 9) and WD-fed (n = 10) mice. Data are means ± SEM. (C) Frequency distribution of the 
number of fenestrae by area for control ND- (left panel, n = 9) and WD-fed (right panel, n = 10) mice. The 
red and blue lines represent the best Gaussian distributions for fenestrae sizes in vessels from ND (red peak 
= 0.82 µm2, blue peak = 1.34 µm2) and WD-fed (red peak = 0.78 µm2) mice. (D) Comparison of the mean 
total fenestra area per unit area in control ND- (n = 9) and WD-fed (n = 10) mice. Data are means ± SEM. 
*P<0.05 vs. control. 
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5.4 Discussion 
 
In the present investigation, a WD (high in fat and sugar) was used to promote 
over nutrition in mice. To the best of our knowledge, this is the first report to examine 
ECM structural changes in the microvasculature as a consequence of a WD and 
subsequent over nutrition/obesity. Our primary finding was that the number of fenestrae 
within the IEL of mesenteric resistance vessels is significantly decreased, as is the total 
area occupied by fenestrae in vessels isolated from male mice fed a WD for 16 weeks. 
This was associated with an increased amount of elastin present in the vascular wall and 
an augmented modulus of elasticity, indicating that mesenteric resistance arteries from 
the WD-fed mice were significantly stiffer.  However, the distensibility of these arteries 
was only modestly affected, as there were only marginal changes in the stress/strain 
characteristics of the vessels from WD-fed mice. A previous study examining structural 
changes in mesenteric arteries in a different model of obesity that is associated with 
diabetes (db/db mice) also found a significantly increased modulus of elasticity in the 
obese cohort (178). The authors of that study also report that arteries from the obese 
cohort displayed outward hypertrophic remodeling and a decreased wall to lumen ratio. 
Though we did not observe outward remodeling, we found a trend for a reduction in wall 
to lumen ratios for the WD cohort, suggesting that similar structural alterations are 
manifest in the mesenteric vasculature of db/db mice and mice fed a WD. The major 
functional difference observed in mesenteric arteries from WD-fed mice in our study was 
a significantly reduced level of spontaneous myogenic tone. A significantly reduced level 
of myogenic tone responsiveness to changes in intraluminal pressure has been shown to 
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occur in resistance vessels isolated form diabetic rats (75). The mechanisms associated 
with the reduced myogenic response observed in diabetic rats was associated with an 
attenuated level of VSMC intracellular calcium at a given intravascular pressure (206). 
Whether a similar mechanism is responsible for the reduced level of myogenic tone we 
observed in the arteries isolated from mice fed a WD remains to be determined. However, 
the physiological significance of this finding may be similar to that proposed to be 
responsible for the outward remodeling found in the mesenteric arteries of db/db mice 
(178), that is, to increase blood flow to a highly active intestinal wall. We did not find 
any additional functional changes between mesenteric vessels from WD- vs. ND-fed 
mice as neither their constriction (KCl, phenylephrine) or relaxation (insulin, SNP) 
responses were significantly different. This suggests that, in animals fed a WD, structural 
alterations to the IEL and vascular stiffness precede functional changes to vasoactive 
stimuli, though additional WD studies of longer duration that test additional 
vasoconstriction and vasodilation pathways will need to be performed to confirm this.  
 
A reduction in the number and area of fenestrae in the IEL of vessels from 
hypertensive rodents has been previously reported (28). To our knowledge this is the first 
description of such a finding in WD-fed mice. The mechanism(s) leading to a decrease in 
total fenestrae, as well as the reduction in total fenestrae area, is/are yet to be determined. 
In this study, the changes in the fenestration of the mesenteric vasculature coincided with 
an increase in elastin volume. A similar link between decreased fenestra area and 
increased elastin content has been reported in two separate rat models of hypertension. 
Neonatal spontaneously hypertensive rats were found to have increased elastin-derived 
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fluorescence in carotid arteries and this was associated with a decrease in the size of 
individual fenestrae (9). A 2-week infusion of angiotensin II to induce hypertension in 
Wistar rats also resulted in a reduced number of fenestrae and a reduction in the total 
fenestrae area in the mesenteric vasculature and this coincided with an increase in the 
relative area occupied by elastin (28). The current observation of increased deposition 
and/or reorganization of elastin within the IEL and a decrease in the number of fenestrae 
suggests a mechanism in which elastin deposition is targeted to sites of fenestration. It 
has previously been shown that in developing mice aorta, newly synthesized elastin 
preferentially accumulates at extant fenestrae (44). Though, how this occurs is unclear. 
Conceivably the borders of fenestrae are biochemically favorable for the 
polymerization/crosslinking of newly synthesized tropo-elastin monomers. Alternatively, 
the enzymes that facilitate polymerization of tropo-elastin monomers, such as fibulins 
and lysyl oxidase (80) and/or transglutaminase 2 (97), could preferentially be targeted to 
sites of fenestration. Additional studies are necessary to define how and where newly 
synthesized elastin is deposited in the microvasculature. Regardless of the underlying 
mechanism of deposition at sites of fenestration, depending upon the amount of elastin 
deposited, one would expect the size of the fenestrae to be reduced as well as eventually 
the overall number of fenestrae. This is consistent with our finding that the distribution of 
fenestrae in vessels from the WD-fed mice was shifted towards smaller sizes. 
 
To determine if signaling for elastin synthesis was increased in the WD-fed mice, 
we used real-time quantitative PCR to measure mRNA levels of tropoelastin in 
mesenteric arteries from the WD- and ND-fed mice.  There was not a significant 
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difference in the level of mRNA between the two cohorts (Fig. 5.10). Thus, it is likely 
that if an increase in elastin production signaling occurs in the WD-fed group, this 
increase occurs during the initial periods of WD feeding at a younger age. 
 
 
Figure 5.10. Real-time quantitative PCR analysis of elastin gene expression. Bars represent the 
relative fold mRNA expression levels for elastin detected in mesenteric resistance arteries isolated from 
mice fed either a CD (control, n=10) or a WD (n=10) for 16 weeks. Data are means ± SEM. 
 
It may also be possible that changes the equilibrium of elastin 
synthesis/degradation to favor increased elastin deposition may occur that do not reflect 
an increase signaling for elastin synthesis. Elastin synthesis is regulated at multiple levels 
including: DNA transcription, mechanisms that affect the stability of existing elastin 
mRNA, mechanisms that affect the enzymes that mediate tropo-elastin monomer 
polymerization and also via mechanisms that regulate ECM proteases that actively 
degrade elastin (98). In particular, the cytokine transforming growth factor–beta (TGF-β) 
has been implicated in elastogenesis via transcriptional as well as post-translational 
modification mechanisms. It stabilizes elastin mRNA in rat (127) and human lung 
fibroblasts (104) via a pathway that includes Smads, protein kinase C, and p38 (105). 
ECM enzymes required for polymerization of tropo-elastin monomers are 
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transcriptionally up regulated (103) and secreted (24) in response to TGF-β. It has also 
been shown that TGF-β suppresses elastin degradation via inhibition of matrix 
metalloproteinase-9 (5). There is also considerable evidence that obesity triggers 
increased expression of proinflammatory cytokines, including TGF-β in adipose tissue in 
rodents (77, 82, 162, 163), as well as humans (4, 56, 81, 96). To test the possibility that 
TGF-β expression may be increased in the WD-fed mice, we performed real-time 
quantitative PCR and Westerns to measure mRNA and protein levels of TGF-β in the 
mesenteric arteries isolated from these mice. We found no differences in TGF-β mRNA 
or protein between arteries from the WD-fed vs. the ND-fed mice (Fig. 5.11). This 
suggests that at the age and time of feeding we measured (20 weeks of age/16 weeks on 
WD) the cytokine, cells within the vasculature are not producing more TGF-β in response 
to WD feeding. It remains to be determined if this is also true at younger ages.    
 
In addition to the release of inflammatory cytokines such as TGF-β, diet-induced 
obesity is also associated with decreased insulin sensitivity and hyperinsulinemia (134). 
In C57Bl/6J mice fed a high fat diet, there was a significant increase in serum insulin 
concentrations versus control fed mice at 30 weeks of age (76). We have demonstrated 
that the diet protocol used in this study leads to a significant increase in plasma insulin 
levels and increased HOMA-IR values, a surrogate index of insulin resistance (Figure 1). 
Interestingly, activation of the insulin receptor via low doses of insulin has recently been 
implicated in inducing the synthesis of tropo-elastin in human aortic smooth muscle cells 
in culture, via transcriptional activation and up-regulation of the secretory pathway that 
delivers tropo-elastin from the endoplasmic reticulum to the cell surface (176). As 
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demonstrated in this study, the vasodilatory response of mesenteric arteries to insulin was 
not affected by the WD. This suggests that signaling via the insulin receptor was not 
impaired within the resistance vasculature of these obese mice. Therefore, the observed 
increase in elastin content within the wall of mesenteric resistance arteries may be due to 
elevated serum insulin concentrations that positively regulate elastogenic pathways via 
activation of insulin receptor signaling. 
 
The physiological significance of reduced total fenestrae area is poorly 
understood. One investigative group reported that conduit/carotid arteries from 1-week 
old spontaneously hypertensive rats had decreased fenestration and this was coincident 
with increased arterial stiffness compared with age matched control rats (9). Moreover, 
these ECM differences were manifest prior to any significant changes in blood pressure 
between the controls and spontaneously hypertensive rats. In the Weisbrod paper, they as 
well report that arterial stiffening increased prior to the onset of hypertension in mice fed 
a WD. Using radio telemetry, we previously demonstrated that the WD used here induced 
a modest increase (8.2%) in systolic blood pressure, in a different cohort of mice at the 
same age (134). In humans, a classification of hypertension entails an approximate 16% 
increase in systolic blood pressure (120 mmHg for normotensive vs. 140 mmHg for 
hypertensive). Thus, we infer that the mice in this study were in the process of 
developing hypertension. In contrast, the observed ECM remodeling was well progressed, 
as the difference in elastin content and IEL fenestration were substantial between the two 
treatment groups, and likely was the result of incremental increases in elastin deposition 
or reduced degradation over time. Therefore, our findings that remodeling of the ECM 
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via decreased fenestration occurred prior to the onset of full-blown hypertension suggest 
that reorganization of the ECM may be one of the first pathological events that triggers 
stiffening and the subsequent development of hypertension in diet induced obesity. 
Within the mesenteric resistance arteries, fenestrae allow for the exchange of 
macromolecules between endothelial cells and the VSMCs that comprise the media. They 
also allow for the projection of endothelial cell membranes to make contact with VSMC 
membranes.  It is posited that these myo-endothelial interfaces allow for the transmission 
of vasoactive elements across the IEL (164, 181). A reduction in total fenestra area would 
likely affect the time it takes for diffusible substances to transit between the intima and 
medial layers, and decreases in the number of fenestrae would decrease the number of 
contacts for the transmission of vasoactive compounds across the IEL. Nitric oxide (NO) 
is one of the main signaling molecules that diffuses across the IEL, and limiting its 
availability has been shown to promote vascular stiffness (131, 187). It has recently been 
postulated that arterial stiffness could arise, in part, from changes in the actin 
cytoskeleton that affect the intrinsic mechanical properties of individual VSMCs, as actin 
depolymerizers reduce VSMC stiffness (174). NO has been shown to facilitate F-actin 
depolymerization in VSMC (167). However, whether the reduced fenestration we 
observed in the mesenteric arteries of WD-fed mice affects transmission of vasoactive 
compounds across the IEL and changes the elastic properties of VSMCs or their capacity 
to develop spontaneous myogenic tone remains to be determined.  
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Figure 5.11. Real-time quantitative PCR and Western blot analyses of TGF-β gene and protein 
expression in blood vessels. (A) Relative fold mRNA expression levels for TGF-β1 detected in mesenteric 
arterioles isolated from mice fed a CD (control, n=10) or a WD (n=10) for 16 weeks. Data are means ± 
SEM.  (B) Western blot showing protein expression of TGF-β and β-Actin in aortas isolated from mice fed 
a CD (control, n=5) or a WD (n=5) for 16 weeks.  (C) Bars represent the relative TGF-β protein expression 
normalized to β-Actin. Data are means ± SEM. 
 
In conclusion, we demonstrate here that a WD rich in fat and sugars induces 
obesity, hyperinsulinemia, insulin resistance, and remodeling of the ECM in mesenteric 
resistance arteries characterized by an increase in elastin volume and a concomitant 
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decrease in fenestrations within the IEL. These changes are associated with a reduced 
level of basal myogenic tone and stiffening of the vascular wall in these resistance 
arteries, in the absence of functional responses to vasoactive agonists. Our results further 
suggest that the changes we observed in elastin content and fenestration of the IEL are 
not associated with an increased message for synthesis of elastin or TGF-β within the 
vasculature of 20-week-old mice.  
 
5.5 Perspectives 
 
 In this study, we demonstrate that a WD rich in fat and sugars induces remodeling 
of the ECM in mesenteric resistance arteries via an increase in elastin content. These 
changes are associated with an increased stiffening of the resistance vasculature and 
appear to precede functional changes to vasoactive agents. We hypothesize that chronic 
release of pro-inflammatory cytokines associated with consumption of the WD and the 
obese state in addition to hyperinsulinemia initiates remodeling of the ECM within the 
vasculature, which subsequently participates in the development of vascular dysfunction 
and adverse cardiovascular pathologies. 
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CHAPTER 6 
JEJUNAL SUBMUCOSAL ARTERIOLES FROM BARIATRIC 
PATIENTS WITH DIABETES HAVE BLUNTED VASODILATORY 
RESPONSE TO INSULIN BUT NOT TO ACETYLCHOLINE 
 
6.1 Introduction 
 
Obesity represents a major health problem affecting millions of people worldwide. 
In United States of America obesity has increased considerably in the last decades. 
Recent studies (139, 140) have shown that in the U.S. about 34.9% of the adults (20 years 
old and over) are obese. In adults between the ages of 40-59 years the obesity levels 
reach their maximum at 39.5%. In average, 27.4% of the adults (25 years old and over) 
die every year as a consequence of heart disease or stroke (74). Obesity increases the risk 
of several pathophysiological conditions, being hypertension and type-2 diabetes two of 
the most important. Type-2 diabetes and obesity are associated with cardiovascular 
disease, which is considered the number-one cause of death nowadays (accounting for 
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more than 24% of the deaths); and endothelial dysfunction, of which the mechanisms 
leading to aberrant insulin-dependent vasodilation have not been completely understood. 
  
In an effort to reduce the incidence of diabetes, cardiovascular diseases and other 
obesity-related morbidities, an increasing number of obese individuals are opting for 
bariatric surgery to reduce their body weight and body mass index (BMI).  
 
Roux-En-Y Gastric Bypass (RYGB) is a type of bariatric surgery in which the 
stomach is first divided into two parts, a smaller upper pouch and a larger lower stomach 
bypassed section. Then the small intestine is re-arranged and re-connected to both parts 
of the stomach, adopting a “Y” shape. This surgical procedure reduces the amount of 
food that can be ingested per meal, limiting the calorie intake and reducing the amount of 
nutrients that are absorbed by the intestines. This helps obese individuals lose weight. 
Furthermore, through mechanisms that still remain to be completely understood, the 
RYGB has been shown to improve cardiovascular function and glucose homeostasis (3, 
31, 49, 100, 150, 159). 
 
Type II diabetes is associated with obesity, and it is characterized by systemic 
insulin resistance. However, not all obese individuals are diabetic, therefore we 
hypothesize that insulin-dependent vasodilation is impaired only in obese individuals 
with diabetes, but not in obese non-diabetic individuals. This would suggest that there is 
an insulin-endothelial specific dysfunction that is directly associated with systemic 
insulin resistance and independent of the degree of obesity.  
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6.2 Materials and methods 
 
6.2.1 Individuals 
Prior to surgery, consent from bariatric-surgery patients was obtained to use a 
section of their jejunum for medical research. This jejunal section is commonly dissected 
and discarded during surgery as part of the RYGB procedure. Individuals included in this 
study were of adult age and had an average BMI of 47.3±0.9 Kg/m2 (Fig. 6.1). Females 
and males were both included in these experiments. 
 
Figure 6.1. BMI (A) and age (B) for non-diabetic and diabetic groups. The number (n) of 
individuals included in each group is indicated in parenthesis. The results are presented as means ±SEM.  
 
6.2.2 Tissue collection and vessel isolation 
During the RYGB surgical procedure, a section of approximately 3 inches of the 
jejunum and mesenteric tissue/fat was excised and placed in a cold (~4°C) physiological 
saline solution in a sealed container that was kept in ice for tissue storage and 
transportation from the surgery room to the laboratory where the experiments were 
performed. For tissue dissection and vessel isolation, the jejunum sample was transferred 
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onto a cooled dissection chamber and placed on a physiological saline solution (PSS) 
containing: 145.0 NaCl, 4.7 KCl, 2.0 CaCl2, 1.0 MgSO4, 1.2 NaH2PO4, 0.02 EDTA, 2.0 
Pyruvic Acid, 5.0 Glucose and 3.0 MOPS (all concentrations are given in mM) with a 
final pH of 7.4. From a small section of the jejunal wall, submucosal arterioles were 
isolated. Mesenteric veins and arteries were also isolated from the jejunal tissue samples 
from each individual. Right after isolation, a set of one mesenteric vein and one 
mesenteric artery was snap frozen and stored at -70°C, and later used for western blotting 
and xMAP multi-plexing. A second piece of mesenteric artery was cannulated, 
pressurized at 80 mmHg and fixed in 4% paraformaldehyde. Fixed arteries were sliced, 
mounted on glass slides and used for various immunohistochemistry and fluorescence  
studies. 
 
6.2.3 Experimental protocols 
 
In-vitro characterization of the functional responses of isolated arterioles  
In order to measure and characterize the contractile and vasodilatory responses, 
isolated jejunal submucosal arterioles were cannulated and pressurized for 
experimentation as previously described (115). Briefly, arteriolar segments of ~1-2mm in 
length were cannulated onto glass micropipettes within an observation chamber (Living 
Systems Instrumentation, Burlington, Vermont) filled with PSS. The arterioles were 
pressurized without flow to 70 mmHg using a Pressure Servo System (Living Systems 
Instrumentation Burlington, Vermont) and PSS containing 0.15 mM bovine serum 
albumin. The observation chamber with the cannulated vessel was transferred to an 
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inverted microscope equipped with a video display and video caliper system (Living 
Systems Instrumentation Burlington, Vermont) to record measurements of wall thickness 
and luminal diameter. After arterioles were warmed up to 37°C and allowed to stabilize 
for 1 hour, their viability was tested by inducing depolarization of the cell membrane via 
exposure to a PSS containing 80 mM KCl. Subsequently, their functional responses to 
increasing concentrations of phenylephrine (10-8 to 10-5 M), insulin (10-9 to 10-5 M) or 
acetylcholine (10-8 to 10-5 M), and sodium nitroprusside (SNP) (10-8 to 10-4 M) were 
recorded. Exposure to phenylephrine tests for adrenergic vasoconstriction, while insulin, 
acetylcholine and SNP test for vasodilatory responses. Insulin and acetylcholine are both 
endothelium-dependent vasodilators and SNP an endothelium-independent one (1, 17, 55, 
87, 95, 129, 147, 172). 
 
Assessment of the elastic properties of arterioles 
The elastic characteristics of the arteriolar wall were studied by performing 
measurements of the diameter at different levels of intraluminal pressure obtained under 
passive conditions (in a Ca2+-free PSS containing EGTA and Adenosine). These 
measurements were obtained for each arteriole at the end of every experiment. The 
intraluminal pressure was varied in increasing steps ranging from 5 to 120 mmHg. 
Maximum internal diameter and wall thickness were recorded, and these data were later 
used to calculate, as previously reported (32, 33), the circumferential stress, strain and 
modulus of elasticity for all vessels included in this study. 
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Confocal fluorescence microscopy for the quantification of the main components 
of the arteriolar wall 
After the assessments of functional responses and elastic properties of the 
arterioles were completed, all vessels were kept at 70 mmHg of intraluminal pressure and 
fixed using 4% paraformaldehyde for 1 hour at room temperature. For imaging, vessels 
were uncannulated rinsed twice in pH 7.3 phosphate-buffered saline (PBS) and once in 
0.1M Glycine for 5 minutes each time to remove any residual paraformaldehyde. Vessels 
were then cannulated onto glass micropipettes within an observation chamber (same as 
when assessing arteriolar functional responses) containing PBS and flushed with 1 mL of 
the same solution to rinse the lumen. Subsequently, vessels were permeabilized via 
incubation in 0.5% TritonX100 in PBS for 20 minutes. After that, vessels were washed 
and their lumens flushed twice with PBS and incubated for 1 hour in a solution 
containing: 0.5µg/mL 4',6-diamidino-2-phenylindole (DAPI), 200 nM Alexa Fluor 633 
Hydrazide (Molecular Probes) and 33 nM Alexa Fluor 546 phalloidin (Molecular Probes) 
in PBS. After incubation and in preparation for imaging, vessels were washed/flushed 3 
times using PBS. Fluorescence images were obtained using a Leica SP5 
confocal/multiphoton microscope with a 63X/1.2NA water objective. Alexa Fluor 633 
Hydrazide, which stains elastin, was excited with a 633 nm HeNe laser. Alexa Fluor 546 
phalloidin binds to actin and was excited with a 543 nm HeNe laser.  Nuclei imaging was 
achieved by exciting DAPI using a multi-photon laser at 700 nm. Collagen structures 
were imaged by capturing their characteristics produced with second-harmonic 
generation (SHG) using a multi-photon laser at 850 nM.  
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Immunohistochemistry of the insulin receptor 
Using mesenteric arteries that were fixed in 4% paraformaldehyde at 80 mmHg of 
intravascular pressure right after dissection, the amount of the different structural-
components of the insulin receptor (IR) were quantified by means of 
immunohistochemistry assays as previously described (66, 67, 201, 202). Briefly, 
ethanol-series rehydrated paraffin-embedded arterial sections were blocked in 5% of BSA, 
5% of donkey serum and 0.01% of sodium azide in HEPES buffer for 4 hours in a 
humidified chamber. Following a brief HEPES-rinse, sections were incubated overnight 
with 1:40 of Insulin Receptor-Alpha (rabbit polyclonal) Antibody and Insulin Receptor-
Beta (rabbit polyclonal) Antibody (Cat. No. 250723 and 250724 from Abbiotec, 
respectively). Incubation in primary antibodies was performed in humidity chambers at 
room temperature. Then, the sections were thoroughly washed with HEPES wash buffer 
(3x 5-minute per wash) and incubated with 1:300 of appropriate secondary antibodies, 
Alexa Fluor Donkey anti-Rabbit (Invitrogen A31572) for 4 hours. After washing, the 
sections were mounted with Mowiol and sealed with nail polish for further examination 
under a confocal microscope. Signal intensities were analyzed with MetaVue and ImageJ. 
Similarly, sections of the same mesenteric arteries were immunostained for quantification 
of the amount (total amount of protein) of the four different substrates of the IR. Other 
sections were stained with Verhoeff-Van Gieson (VVG). Brightfield microscopy images 
were obtained from these sections and analyzed to measure luminal diameter and media 
thickness of these mesenteric arteries. 
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xMAP-multiplexing for quantification of MMPs and TIMPs 
Arteries (~3-5mm long sections) isolated from the mesenteric fat located in the 
vicinity of the jejunum were snap frozen and stored at -70°C. Later, samples from all the 
patients included in this study were taken out from the freezer and transferred into 0.5 mL 
homogenizer tubes (Omni International) containing 400 µL of RIPA buffer with halt 
protease and phosphatase inhibitor cocktail (Thermo Scientific #78440). Arteries were 
then homogenized using 1.4 mm zirconium oxide beads (20 per tube) and an Omni Bead 
Ruptor 24 (Omni International). Subsequently, homogenates were transferred into new 
tubes and centrifuged for 3 minutes at 10,000 rpm using an Eppendorf 5415D centrifuge. 
Supernatants were then collected and transferred into new tubes for re-centrifugation at 
13,000 rpm for 10 minutes to ensure proper debris precipitation. Finally, homogenates 
were split into two parts and ran as duplicates in a BioPlex 200 system using the 
Milliplex Map kits Human MMP (Matrix Metalloproteinase) Panel 2 Magnetic Bead Kit 
and Human TIMP (Tissue Inhibitors of Matrix Metalloproteinase) Panel 2 Magnetic 
Bead Kit respectively. These kits allowed for the quantification of the amount of MMPs 
(MMP-1,2,7,9,10)  and TIMPs (TIMP-1,2,3,4). 
 
6.3 Results 
 
6.3.1 Smooth-Muscle-Cell (SMC) membrane depolarization- and adrenergic-
induced vasoconstrictions were not affected by presence of diabetes 
Depolarization of the SMC-membrane via exposure of isolated and pressurized 
jejunal submucosal arterioles to an 80 mM KCl PSS induced strong and sustained 
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vasoconstriction. Similar, not statistically significantly different, constriction levels were 
observed in arterioles from diabetic and non-diabetic individuals (Fig. 6.2-A). 
Correspondingly, exposure to increasing concentrations of phenylephrine (10-8 to 10-5 M) 
induced similar adrenergic-receptor dependent vasoconstriction in both diabetic and non-
diabetic groups (Fig. 6.2-B). 
 
 
Figure 6.2. (A) Viability of jejunal arterioles was assessed by exposure to a PSS containing 80 
mM KCl. Constriction to KCl is presented as a percent of the tone prior exposure. (B) Adrenergic-receptor 
dependent vasoconstriction at different increasing concentrations of phenylephrine. Constriction is reported 
as a percent of the maximum vasoconstriction achieved at 80 mM KCl. The results represent means ±SEM 
of the n number of experiments that were performed.  
 
6.3.2 Arterioles from bariatric patients with diabetes have blunted response 
to insulin but not to acetylcholine 
Endothelium-dependent vasodilation was tested on jejunal arterioles by exposing 
them to increasing concentrations of either insulin or acetylcholine and subsequently to 
SNP. Vasodilatory responses were assessed after pre-constriction with phenylephrine (10-
6 M). When testing insulin-vasodilation, a blunted vasodilatory response was observed 
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for arterioles from bariatric diabetic-patients. In the diabetic group, the maximal insulin-
dependent vasodilation (dilation to insulin 10-5 M) was 23.6±6.9% smaller (p<0.05) than 
that in the group of non-diabetic patients (Fig. 6.3-C,D). However, the vasodilation 
induced by acetylcholine or SNP were not significantly different between these two 
groups (Fig. 6.3-A,B). 
 
 
Figure 6.3. Endothelium-dependent vasodilation was assessed by means of exposure to increasing 
concentrations of acetylcholine (A) and insulin (C). (B) Characterization of endothelium-independent 
vasodilation using increasing concentrations of SNP. Panel (D) shows the mean difference in vasodilation 
at the maximum concentration (10-5 M) of Insulin. The results represent the means ± SEM. * p<0.05 vs 
non-diabetic group. 
 
A B
-8 -7 -6 -5
0
20
40
60
80
Acetylcholine (log M)
%
 D
ila
tio
n 
fro
m
 P
he
 1
0-
6 M
Non-Diabetic (n=18)
Diabetic (n=11)
-8 -7 -6 -5 -4
0
20
40
60
80
100
SNP (log M)
%
 D
ila
tio
n 
fro
m
 P
he
 1
0-
6 M
Non-Diabetic (n=20)
Diabetic (n=17)
C D
-9 -8 -7 -6 -5
0
20
40
60
80
Insulin (log M)
%
 D
ila
tio
n 
fro
m
 P
he
 1
0-
6 M
Non-Diabetic (n=22)
Diabetic (n=16)
*
***
-5.5 -5.0 -4.5
0
20
40
60
80
Insulin (log M)
%
 D
ila
tio
n 
fro
m
 P
he
 1
0-
6 M
23.57%
(p<0.05)
! 111!
6.3.3 Elastic and mechanical properties of jejunal submucosal arterioles from 
bariatric patients 
Assessment of the elastic/mechanic properties of the jejunal submucosal arterioles 
after characterization of their functional responses showed that arterioles from diabetic 
patients had a tendency to have an increased stiffness when compared to those vessels 
from non-diabetics (Fig. 6.4). However, these results were not significantly different.  
 
 
Figure 6.4. Assessment of the elastic properties of jejunal arterioles from non-diabetic and diabetic 
individuals. (A) Luminal diameter as a function of the intraluminal pressure. (B) Strain-stress relationships. 
(C) Modulus of elasticity at different intraluminal pressures. (D) Wall-to-Lumen ratios for both groups as 
functions of pressure. These results represent the mean ± SEM.  
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6.3.4 Vascular-wall media thickness and cross-sectional area of jejunal 
arterioles are increased in diabetics, while densities of actin and SMCs nuclei are 
reduced  
Although the raw measurements of total expression of actin, elastin, nuclei and 
collagen were not statistically different between diabetics and non-diabetics, the 
normalized amounts of actin and nuclei-volume per unit of vascular-wall volume were 
found significantly smaller in arterioles from diabetic patients (Fig. 6.5-A,B). This is 
consistent with the fact that although these arterioles had similar luminal diameters, they 
had significantly increased wall thickness increasing the cross-sectional area of the 
arteriolar wall; in particular, arterioles from diabetics had more volume between the 
elastic laminas (Fig. 6.6-A,B). By implementing a Matlab script, images of the elastin 
fibers that conform the elastic laminas where analyzed to look at the different angles of 
orientation. These fibers seem to be oriented in a preferential orientation, at 15 degrees; 
however there was no difference between groups (Fig. 6.6-C,D).  
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Figure 6.5. Quantification of actin, elastin, nuclei and collagen by confocal microscopy in jejunal 
arterioles. (A) Raw number of voxels with expression of actin, elasitn, nuclei or collagen. (B) Density of 
voxels per unit-volume of the vascular wall. These results represent the values on panel (A) normalized to 
the total available volume within the internal and external elastic laminas. (C) Density of voxels per unit-
area of the elastic laminas. These results represent the raw numbers for elastin and collagen from panel (A) 
normalized to the total surface area associated with the internal and external elastic laminas in the case of 
elastin; and to the total surface area of the external elastic lamina for collagen. Results are means ± SEM in 
each case. * p<0.05 vs non-diabetic group. 
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Figure 6.6. (A,B) Cross-sectional area (CSA) and media thickness (C,D). Orientation-angles of the 
elastin fibers with respect to the longitudinal direction. Mean ± SEM for each group. * p<0.05 vs non-
diabetic group. 
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6.3.5 The extracellular subunit of the insulin receptor is cleaved in arteries 
from diabetic bariatric patients 
 Immunohistochemistry and fluorescence microscopy techniques were utilized on 
mesenteric arteries to look at the amount of the two different subunits (extracellular α-
subunit and transmembrane β-subunit) that constitute the insulin receptor (IR). The 
results showed a reduced amount of the extracellular subunit on mesenteric arteries from 
bariatric patients diagnosed with diabetes (Fig. 6.7-A,C). No significant differences were 
observed for the amount of the transmembrane subunit (Fig. 6.7-B,D). The reduction in 
the α-subunit of the IR was consistently observed through all the layers (i.e. intima, 
media and adventitia) of the vascular wall (Fig. 6.7-C ).  
 
6.3.6 Presence of the insulin receptor substrates is similar in patients with 
and without diabetes 
Immunohistochemistry and confocal microscopy was also used to quantify the 
amount (total amount of protein) of the four known different substrates of the IR in 
mesenteric arteries from diabetic and anon-diabetic patients. Fluorescence quantification 
showed non-statistically significant differences in the amount of protein associated with 
all substrates between the groups (Fig. 6.8). 
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Figure 6.7. Immunohistochemistry and confocal microscopy to quantify: the amount of the 
extracellular insulin receptor α subunit (A) and the transmembrane insulin receptor β subunit (B). The 
quantification is expressed as total intensity per unit-area in the different sections of the vascular wall 
(intima, media and adventitia), and the results are presented as means ± SEM. * p<0.05 vs non-diabetic 
group. 
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Figure 6.8. Quantification of the four insulin-receptor substrates in mesenteric arteries from 
diabetic and non-diabetic bariatric patients using immunohistochemistry and confocal microscopy. Total 
amount of protein associated with each substrate was quantified. The results are expressed as means ± SEM.  
 
6.3.7 Matrix-Metalloproteinase-9 (MMP-9) is reduced in mesenteric arteries 
from diabetic patients 
Multi-plexing assays to measure the amount of MMPs (MMP-1,2,7,9,10) and 
their tissue inhibitors (TIMPs 1-4) on homogenates from mesenteric arteries. The results 
showed that from the various MMPs that were assessed, the amount of MMP-9 present in 
arterial-tissue from diabetic patients was significantly reduced compared to non-diabetic 
samples (Fig. 6.9-A). No significant differences were observed when assessing the 
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presence of the different tissue inhibitors of the MMPs (Fig. 6.9-B). The ratios of the 
MMPs 2,9 to the different TIMPs were calculated. MMP-9/TIMP-1 and MMP-9/TIMP2 
were significantly smaller in the arteries from diabetics (Fig. 6.9-D). 
 
6.3.8 Mesenteric arteries from diabetic patients have increased media 
thickness and increased media-to-lumen ratio 
Sliced sections, from the same mesenteric arteries used for the quantification of 
the IR subunits and IR substrates, were stained following the Verhoeff-Van Gieson 
(VVG) staining protocol. The results from brightfield microscopy imaging showed that 
mesenteric arteries from both, diabetics and non-diabetics have similar luminal diameters. 
However, the arterial-wall media was significantly increased in thickness, resulting in 
presence of  increased media-to-lumen ratios in arteries from diabetic patients (Fig. 6.10). 
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Figure 6.9. Quantification of the levels of MMPs and TIMPs in homogenized mesenteric arteries 
using multiplexing. These results represent the concentration measurements per unit of volume (mL). The 
results are expressed as mean ± SEM for diabetic and non-diabetic groups respectively. * p<0.05 vs non-
diabetic group. 
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Figure 6.10. Morphometric analysis of mesenteric arties from diabetic and non-diabetic bariatric 
patients stained with VVG. The diameter results in panel (A) represent the reconstructed values from 
perimeter measurements. (B) Media thickness. (C) Media-to-Lumen ratio. (D,E) Representative images of 
a sliced mesenteric artery using 4x and 40x objectives (400 and 40 µm scale-bars) respectively. * p<0.05 vs 
non-diabetic group. 
 
6.4 Conclusions and discussion 
The connection between obesity and vasculature-related diseases has been widely 
studied. The effects of obesity on large arteries have been shown to increase the risk 
factors for myocardial infarction, stroke and hypertension (25, 158). Structural and 
functional changes in the microvasculature have also been shown to increase in obesity 
(30, 65, 84). Obesity has been also associated with diabetes; furthermore, these two 
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diseases have been associated with insulin resistance and endothelial dysfunction. 
However, whether insulin resistance and endothelial dysfunction are directly associated 
in obesity, and whether one is a necessary condition for the other, remains unknown; and, 
the mechanisms through which the microvasculature is damaged in obesity remain to be 
fully understood.  
 
In this manuscript, we showed that micro-vessels from the jejunal submucosa of 
diabetic obese bariatric-patients presented a reduced dilation to increasing concentrations 
of insulin, when compared to non-diabetic obese individuals. In contrast, dilations to 
increasing concentrations of acetylcholine remained at similar levels for both groups. 
This blunted-response to insulin occurring in the absence of an abnormal acetylcholine-
induced dilation suggests that the mechanisms responsible for this endothelial 
dysfunction are upstream of eNOS activation. The problem may be found at the level of 
the insulin-receptor itself. Indeed our results indicate that the extracellular portion of the 
IR is significantly reduced in diabetic vs. non-diabetic vessels. Because the 
transmembrane portion of the receptor was not reduced, this suggests that the 
extracellular portion was likely cleaved or shed from the cell membrane.  Originally, we 
suspected that changes in the activity or proportion of MMPs, TIMPs and ADAMs (A 
disintegrin and metalloproteinases), known for their sheddase-properties in cleaving 
extracellular portions of transmembrane receptors, could be responsible for cleaving the 
IR extracellular component (10, 47, 133, 169). Our results indicate that there are changes 
in the proportion of MMP in the vascular wall of diabetic patients and suggest that, the 
responsible mechanism(s) may be associated with changes in the activity of matrix 
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metalloproteinases. As already mentioned, our results on the quantification of the 
expression of the different subunits of the IR support our original idea of the cleavage of 
the insulin receptor subunits (reduced extracellular subunit-α); however, contrary to what 
we expected, MMPs, in particular MMP-9, were reduced in mesenteric arteries from 
diabetic patients. This reduced expression of MMPs (specifically MMP-9) suggests that, 
in Type-2 diabetes, the mechanism(s) responsible for a blunted-response to insulin may 
be related with the expression/activity of MMPs (58, 79, 109, 144, 189, 207). We suspect 
that MMPs are indeed increased in diabetes, and may be the responsible for the shedding 
of the insulin receptor, but they are being secreted and released into the blood stream, 
increasing the concentration of circulating MMPs. Meanwhile the amount of MMPs 
present in the actual tissue, as in our case, may be reduced.   
 
Although we did not observe a significant change in the elastic properties of 
jejeunal submucosa arterioles between groups, we did observe a tendency for arterioles 
from diabetics to be stiffer and have increased wall thickness and increased wall-to-
lumen ratios. These results were confirmed by means of fluorescence/confocal 
microscopy, where it was shown that the density of expressed-voxels per unit of volume 
of the vascular wall (available volume between elastic laminas) for actin and nuclei were 
both significantly reduced in arterioles from diabetic individuals. The actin-to-nuclei ratio 
did not change between groups, meaning that the total amount of actin present per 
smooth muscle cell was the same. It was just the available volume within elastic laminas 
that was increased. This result was confirmed when the thickness of the media was 
measured and was found significantly increased in diabetic vessels. These observations 
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are consistent with the results from VVG-stained sliced-sections of mesenteric arteries. 
There we found that luminal diameters did not change between diabetics and non-
diabetics, but the media thickness was significantly increased in the diabetic groups.  
 
The results reported in this document suggest that in obesity, the vascular wall, 
specifically the media, undergo structural modifications that result in an increased 
volume, while the amounts of actin and number/volume of nuclei remain unchanged. 
Perhaps collagen of a type other than the one we measured here is filling this space. 
Furthermore, our results suggest that in obesity and type-2 diabetes, the endothelial 
dysfunction that results in a reduced dilation to insulin accompanies the systemic insulin 
resistance that is associated with type-2 diabetes, but this endothelial dysfunction is 
independent of the degree of obesity that an individual presents. 
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